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ABSTRACT 
 
Regulation of Mammary Lactogenic Differentiation by Singleminded-2s. (May 2009) 
Elizabeth Ann Wellberg, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Weston W. Porter 
 
 Sim2s is a basic helix-loop-helix Per-Arnt-Sim (bHLH-PAS) transcription factor.  
In Drosophila, the Sim2 homolog, sim, is necessary for cell fate determination during 
central nervous system (CNS) development.  In mammals, both Sim2 isoforms are 
involved in development of various tissues, including muscle, cartilage, and mammary 
gland.  Loss-of-function studies revealed a role for Sim2s in specifying epithelial cell 
fate during mammary development and inhibiting growth and invasion of aggressive 
breast cancer cells.  This study determined the role of Sim2s in mammary epithelial cell 
differentiation.  Our hypothesis is that Sim2s is sufficient to promote lactogenic 
differentiation in vivo, characterized by expression of lactation-specific genes.  Two 
models were used to test this hypothesis:  (1) a transgenic mouse, expressing Sim2s 
under control of the MMTV-LTR, and (2) the mouse mammary epithelial cell line 
HC11.  Together, these models allow analysis of the effect of Sim2s on global mammary 
gland differentiation and the mechanism through which it accomplishes this in a 
relatively homogenous population of cells.   
 We determined that precocious expression of Sim2s in vivo is associated with 
upregulation of a subset of milk protein genes in nulliparous females.  During early 
 iv
pregnancy, Sim2s regulation of lactogenic differentiation extended to a larger group of 
genes.  Following pup removal, Sim2s appears to promote survival of alveolar epithelial 
cells.  In vitro, Sim2s expression is necessary for maximal Csn2 expression, as 
determined by loss-of-function studies.  Overexpression of Sim2s is sufficient to enhance 
prolactin-mediated Csn2 expression.  Chromatin immunoprecipitation assays performed 
in HC11 cells revealed enhanced recruitment of Stat5a and RNA Polymerase II 
(RNAPII) to the regulatory region of Csn2 in the presence of Sim2s.  In addition, Sim2s 
and RNAPII were found in a complex that was localized to both the promoter and 
coding region of the Csn2 gene.   
 These studies support the idea that Sim2s is upregulated in a developmental 
stage-specific manner in the mouse mammary gland to promote the survival and 
differentiation of alveolar epithelial cells expressing high levels of milk protein genes.  
Further, Sim2s may regulate the function of a specific subset of alveolar cells by 
targeting the RNAPII holoenzyme complex to genes expressed during lactogenic 
differentiation. 
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NOMENCLATURE 
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CHAPTER I 
INTRODUCTION: MAMMARY GLAND DEVELOPMENT 
 
 The mammary gland is an excellent model for the identification of factors that 
are involved in the development and differentiation of an organ.  It is composed of a 
network of ducts, made of inner luminal epithelial cells and outer myoepithelial cells, 
which are embedded in a matrix of fibroblasts, adipocytes, vasculature, immune cells, 
and connective tissue.  Some rudimentary development takes place in utero, but most of 
the ductal branching and cellular differentiation happens after birth.  In young females, 
mammary development is linear, and during reproduction, the gland undergoes cycles of 
differentiation and regression.  Please refer to Figure 1 for a diagram of the phases of 
mammary gland development and associated structures.  The mammary epithelium is 
susceptible to oncogenic transformation; however to understand how various factors are 
involved in mammary cancer formation or suppression, it is imperative to elucidate the 
normal developmental and differentiation processes of the tissue. 
 
Embryonic Mammary Gland Development 
 In mice, mammary gland development begins during mid-gestation, at 
approximately embryonic day 10.5 (E10.5) (Hens and Wysolmerski 2005).  Formation 
of a mammary or milk line is the first indication of the mammary structures.   
__________________ 
This dissertation follows the style of Genes & Development. 
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Five pairs of condensed, rounded placodes then form on the surface of the epithelium at 
E11.5, in the order 3, 4, 1, 5, and 2.  Placodes 1-3, 4 and 5 become the thoracic and 
inguinal glands, respectively.  Invagination of the mammary epithelium into the 
condensed mesenchyme takes place between E11.5 and E12.5.  In females, the invading 
epithelial bulb begins to elongate into a primary duct that, at birth, has approximately 
15-20 branches.   
 
 
 
 
 
Figure 1.  Phases of Mouse Mammary Gland Development.  Courtesy of Mike Lewis, Ph.D., 
Baylor College of Medicine.  A, Mammary line at E11.5.  B, Mammary bud.  C, Mammary Sprout.  
D.  Whole mounted (WM) mammary gland from parous female.  E.  WM mammary gland at 
involution day 3.  F.  WM prepubertal mammary gland.  G.  WM juvenile gland showing TEB 
structures.  H.  WM mature mammary gland.  I,  WM mammary gland at pregnancy day 10.  J, 
WM mammary gland during lactation.     
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 Studies performed in mice lacking ESR1, ESR2, Pgr, GHR, or PrlR revealed that 
embryonic mammary development is hormone-independent (Hens and Wysolmerski 
2005) .  Several investigations have been done to determine the gene expression 
requirements for the formation of placodes and mammary buds, and it has been found 
that members of the Wnt, FGF, Tbx, and PTHrP family play important roles in 
embryonic mammary development (Hens and Wysolmerski 2005).  The ability to 
determine the stage of gestation in mice and accessibility of the embryonic tissue 
throughout development makes the mouse an excellent model to use for the study of 
mammary gland formation; however, the rapid development of the embryo makes it 
difficult to pinpoint specific stages at which some structures develop.  The mammary 
line, for example, was described as an anatomical structure in developing rabbit embryos 
more than 30 years ago (Veltmaat et al. 2003).  The existence of such a structure in mice 
was controversial until 2004, when it was detected in mice, at E11.75 (Veltmaat et al. 
2004).   
 For my research, I have used the mouse as a model; therefore, the following 
sections, will describe the development of the mouse mammary gland beginning in the 
embryo.  The cycles of growth and regression that occur during pregnancy and 
involution, respectively will also be discussed.  Throughout the introduction, I will 
discuss the development of the human mammary gland if it has been described, in as 
much detail as is known today, and also discuss some highlights of experiments 
performed in other species such as cows, goats, rabbits, and rats.  The structural 
characteristics of human mammary gland development have been described, yet it 
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remains to be determined if the same gene families are involved in both mouse and 
human development.  In addition, some of the differences in the mouse and human 
mammary gland will be discussed to illustrate the care that should be taken when 
extrapolating findings from mouse models to human development.   
 
Formation of the Mammary Line and Placodes 
 The onset of mouse mammary gland development begins with the formation of 
the mammary or milk line.  Until 2004, the description of this line as an anatomical 
structure was only revealed from studies performed in rabbit embryos (Veltmaat et al. 
2004).  The first indication that such a structure existed in the mouse embryo was 
discussed in a review by Veltmaat and colleagues (Veltmaat et al. 2003).  A mouse 
engineered to express TOPGAL, a beta-galactosidase gene under control of a promoter 
that was inducible by Lymphoid Enhancer Factor/T Cell Factor (LEF/TCF) family 
members and beta-catenin, was described in 1999 in a study examining hair follicle 
formation (DasGupta and Fuchs 1999).  This mouse was used to investigate the role of 
canonical Wnt signaling in mammary gland development and was generated following 
publication of a study that cited a lack of teeth, hair follicles, and mammary glands in 
Lef1-/- mice (van Genderen et al. 1994).  Additionally, mice engineered to express the 
Wnt inhibitor, Dkk1, under control of a keratin 14 promoter ubiquitously expressed 
throughout the dermis, did not develop mammary buds.  The review in 2003 cited 
personal communication from Dr. Wysolmerzski in the description of TOPGAL 
expression forming two lines extending from forelimbs to hindlimbs of male and female 
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mouse embryos at E10.5.  This suggested that Wnt expression and signaling was the first 
step in formation of the mammary line, and subsequent mammary glands (Veltmaat et al. 
2003).  In 2006, data from the TOPGAL reporter mouse was published, revealing that 
initial Wnt signaling was seen in the mammary mesenchyme, but shifted to the 
epithelium at E12.5.  In addition, expression of Patched-1, which is a target of the 
Hedgehog (Hh) signaling pathway, was reduced in the mesenchyme surrounding the 
mammary placodes in Lef1-/- mice.  Together, these studies reveal a requirement for Wnt 
signaling in the induction of mammary growth, and for proper integration of other 
signaling pathways, such as that mediated by Hh ligands, during embryonic mammary 
formation (Boras-Granic et al. 2006).   
 Early in 2004, in situ hybridization experiments were published that revealed 
Wnt10b and Wnt6 to be the earliest expressed Wnts along the presumptive mammary 
line.  Further, Veltmaat, and colleagues described the appearance of a cuboidal, 
pseudostratified epithelial layer of cells adjacent to squamous dermal epithelial cells 
from the forelimb to hindlimb at E11.75.  This slightly raised anatomical structure 
appeared 0.5 days after the appearance of a continuous line of Wnt10b expressing cells 
in the same region.  This was the first description of a mouse mammary line analogous 
to that seen in rabbit embryos.  Later in 2004, Chu and colleagues published the data 
collected from the TOPGAL reporter mouse (Chu et al. 2004).  Since the TOPGAL 
reporter was activated at E10.5 and expression of Wnt10b, as determined by in situ 
hybridization, was not detected until E11.25 (Veltmaat et al. 2004), it seemed as though 
another molecule may act in parallel or upstream of Wnt signaling to activate Wnt 
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downstream targets, and initiate the process of mammary development.  Interestingly, 
expression of Wnt10b and Wnt6 in E11.25-E11.75 embryos is fragmented and not 
continuous along the mammary line, and corresponds with the underlying somites 
(Veltmaat et al. 2004).  It has been proposed that a signal from the dermamyotome, or 
the dorsal region of the somite, specificies the mammary epithelial cells and initiates 
formation of the line and placode (Veltmaat et al. 2006).    
 The fibroblast growth factor (FGF) family members are required for mammary 
gland development in the mouse embryo (Mailleux et al. 2002).  Fgf10 is expressed in 
the dermamyotome at E10.5, and mammary glands 1, 2, 3, and 5 fail to develop in mice 
lacking Fgf10, making it an excellent candidate for the molecule responsible for 
specification of the mammary epithelium.  Loss of Fgfr2IIIb results in the same 
phenotype as that of Fgf10-/- mice.  Fgfr2IIIb, which encodes the receptor for Fgf10, is 
expressed in the epithelium from E10.5 to E11.5, and its ligand in the underlying 
condensed mesenchyme.  Communication between the compartments is thought to be 
necessary for cell fate determination.  Wnt and Fgf signaling and Tbx3 are thought to 
have a reciprocal relationship.  Tbx3-/- mice have no mammary placodes and do not show 
regional expression of Wnt10b or Fgf10, placing this gene upstream of Wnt and FGF 
signaling pathways.  Alternatively, Tbx3 expression is induced by Fgf in the mammary 
line of cultured embryos (Eblaghie et al. 2004) also placing it downstream of this 
pathway.  During development, Tbx3 is expressed along the mammary line at E10.25, so 
it too could be involved in specification of this structure (Eblaghie et al. 2004).   
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 Shortly after specification of the mammary line, condensed, raised placodes form 
on the epidermis.  Cells in these placodes express Wnts, Fgfr2IIIb, and other genes 
involved in cell migration and proliferation.  Ectodysplasin (Eda), a tumor necrosis 
factor (TNF) ligand superfamily member, and its receptor, EdaR, are expressed in the 
mesenchyme and epithelial placode cells, respectively (Pispa et al. 2003).  
Overexpression of Eda in mice results in supernumerary and enlarged mammary 
placodes along the mammary line (Mustonen et al. 2003).  EdaR signaling is thought to 
promote placode formation and could be involved in directing the positions of the 
placodes along the line.  As supernumerary placodes develop exclusively along the 
mammary line in the embryo with Eda overexpression, it is likely that the Eda/EdaR 
pathway lies downstream of specification of the mammary epithelium.      
      
Bud and Sprout Formation 
 The mesenchyme plays a critical role in the specification and growth of the 
mammary epithelium, and this is not limited to embryonic development.  After E12.5, 
there is a resting phase in development, characterized by an absence of DNA synthesis 
for 24 hours.  Until this point, male and female embryos develop identically.  At E13.5, 
gonadal gene expression leads to production of androgens in male embryos.  This is one 
important difference between mouse and human mammary development.  In human 
males, the mammary bud does not regress as it does in mice; instead, it remains 
underdeveloped but is still susceptible to oncogenic transformation, although this is a 
relatively rare occurrence (Fentiman et al. 2006).  In male mouse embryos, PTHrP 
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signaling in the mesenchyme induces expression of the AR (Dunbar et al. 1999).  
Activation of mesenchymal AR by circulating androgens causes condensation and 
eventual disconnection of the developing sprout from the nipple region, and ultimately 
the male bud degenerates.  Interestingly, this does not take place in Testicular 
Feminization Syndrome mice, lacking androgen production.  Further, tissue 
recombination studies, performed on embryos of both sexes, reveal a mesenchyme-
dependent effect of male mammary degeneration (Drews and Drews 1977).   
 Once the fate of the epithelial cells has been established as ‘mammary’, the 
function of the tissue depends on the epithelium.  The structure of the gland, however, is 
still dependent on the mesenchyme.  The fat pad begins differentiating around E15 to 
E16.  This corresponds to the renewed growth of the mammary epithelium after the 
resting phase.  In females, with the onset of adipogenesis in the fat pad comes 
proliferation of the epithelial cells and elongation of the primary duct.  A requirement of 
the differentiating fat pad was revealed from experiments combining E17 mammary 
epithelium and E14 mesenchyme, and transplanting the tissue under the kidney capsule 
in mice.   Short hyperplastic branches were formed in the presence of condensed, 
undifferentiated mesenchyme, in contrast to the longer, less proliferative branches 
formed in adipocyte-rich mesenchyme (Sakakura et al. 1982).  
 Tissue recombination and transplant techniques have been widely used in the 
study of mammary gland development.  A role for mammary-specific mesenchyme was 
established in 1976 with the classic study by Sakakura and colleagues (Sakakura et al. 
1976).  Salivary gland rudiments from E14 mice and mammary epithelial buds from E16 
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mice were recombined and transplanted under the kidney capsule of 4 week old females.  
The morphology of the outgrowths resembled salivary gland structure, showing the 
importance of mesenchymal instruction in ductal patterning.  When the outgrowths were 
harvested from females that were 5-10 days post-partum, it was determined that 
lobuloalveolar development had taken place in the recombined tissue, and that the ducts 
were distended with milk (Sakakura et al. 1976).  By the time the female mouse is born, 
her mammary bud contains 10-15 branches and occupies a small fraction of her adipose-
rich fat pad. The growth of the juvenile mammary gland is isometric until acted on by 
circulating hormones, released when the female begins sexual maturation. 
  
Adolescent Development 
 Once the female enters puberty, hormones, in cooperation with locally acting 
factors, induce formation of enlarged, club-like structures at the ends of the rudimentary 
branch points.  These terminal end buds (TEBs) are the motile units of the adolescent 
mammary gland.  They are responsible for generating the entire ductal structure, 
correctly spaced and distributed throughout the mammary fat pad.  TEBs are composed 
of an outer layer of cap cells that eventually give rise to the basal myoepithelial cell 
layer, and several layers of inner, body cells, which are the luminal cell precursors.  
Pubertal hormones and stromal-epithelial interactions are largely responsible for the 
correct formation of the adult mammary gland (Figure 2). 
 Transplant studies showed that the stromal environment ultimately patterns the 
adult epithelial structure and morphology.  When epithelium from a strain of mouse with 
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highly branched mammary ducts is grafted into stroma from a lesser-branched strain, the 
resulting outgrowth resembles that of the recipient strain rather then the donor (Naylor  
and Ormandy 2002).   
 Figure 2.  Stromal-Epithelial Interactions Governing Adolescent Mammary Development.  Adapted 
from Sternlicht, et. al., 2000.   
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 The mouse and human mammary glands differ greatly in their stromal 
compositions and branching morphology, but human cells will not form their 
characteristic, lobular pattern when transplanted into a mouse mammary fat pad 
(Kuperwasser et al. 2004).  In mice, the stroma is composed mostly of adipocytes that 
are found uniformly engorged regardless of their proximity to the ducts.  In humans, 
however, the stroma varies.  Large adipocytes can be found between the lobules, but the 
stroma supporting an individual lobule is dense and composed of fibroblasts.  Since we 
have already begun to realize the importance of the mesenchyme and stroma to the 
growth of the epithelium, it will be interesting to determine if the stromal-epithelial 
interactions during human development were correctly modeled by the mouse.    
 The extracellular matrix (ECM) composition is thought to play an important role 
in guiding the movement of TEBs.  Cell proliferation within the TEBs, combined with 
Type I Collagen deposition along the neck of the structure, are responsible for pushing 
the growing duct forward into the fat pad.  This condensation of the ECM is also 
believed to play a role in bifurcation and turning of the invading TEB.   
 Other stromal components known to participate in regulation of ductal outgrowth 
include macrophages and eosinophils.  Using IHC, Gouon-Evans and colleagues showed 
that both macrophages and eosinophils are found scattered throughout the developing 
adolescent mammary gland, interspersed in the TEBs, and highly concentrated around 
the neck of the advancing TEBs (Gouon-Evans et al. 2000).  Macrophages are 
differentiated cells from the mononuclear phagocytic lineage, and require colony 
stimulating factor 1 (Csf1) from tissues for their survival, differentiation, growth, and 
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recruitment.  After irradiating mice, and thus eliminating macrophages, it was revealed 
that the ductal tree was stunted and had reduced branching.  Bone marrow transplants 
performed two hours after irradiation were able to rescue the growth defect.  Using a 
Csf1-/- mouse, which has numerous abnormalities including reduced fertility, dense 
bones, malformed teeth, and low immune cell numbers, the same group showed that 
TEB formation was delayed, and overall TEB number was reduced, leading to decreased 
ductal branching.  Additionally, ducts that formed were often disoriented (away from the 
end of the fat pad) and the fat pad itself was atrophied.  Treatment with recombinant 
human Csf1 rescued the developmental defects and implantation of estrogen pellets, 
used to ensure the outgrowth abnormalities were not due to ovarian dysfunction, did 
nothing to change the effect of Csf1 loss (Gouon-Evans et al. 2000).     
 Eotaxin is a chemoattractant for eosinophils, which also play a role in immune 
response.  Using eotaxin-/- mice, Gouon-Evans and colleagues also evaluated ductal 
outgrowth and TEB formation (Gouon-Evans et al. 2000).  While ductal length was not 
affected by loss of eosinophil recruitment, TEB formation and ductal branching were 
both reduced.  These studies reveal a role for differentiated immune cells in proper 
mammary tree formation and branching.  It is likely that the macrophages and 
eosinophils secrete factors responsible for changes in ECM composition or that instruct 
epithelial cells to proliferate.  The macrophages located within the advancing TEB are 
thought to be responsible for clearing apoptotic epithelial cells and for proper lumen 
formation (Gouon-Evans et al. 2000).   
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 While the stroma and its components play crucial roles in the proper 
development and morphogenesis of the adolescent mammary gland, it is the interaction 
between it and the epithelium that is instrumental for accurate patterning and to maintain 
the balance between proliferation and apoptosis during ductal elongation.  Using 
ovarectomy, hypophysectomy, and conditional knockout approaches, researchers have 
uncovered important interactions between circulating pubertal hormones, stromal 
components, and epithelial cells.  Circulating growth hormone (GH), released from the 
pituitary gland during puberty, binds receptors in the mammary stroma, and causes 
production and release of IGF-1, which binds its receptor on adjacent epithelial cells.  
IGF1R activation then promotes ductal elongation.  Treatment with either estrogen (E2) 
or progesterone (P4) can enhance the effect of IGF1 on elongating ducts, but neither 
hormone alone produces the same results (Sternlicht 2006).  The requirement for ESR1 
is somewhat controversial and has been shown to be stromal (Cunha et al. 1997), 
epithelial (Mallepell et al. 2006), and both (Mueller et al. 2002).  E2 can activate EGFR 
and EGFR ligands can rescue ductal elongation defects in ovarectomized and ESR1-/- 
mice.  The only endogenous EGFR ligand produced in the mammary gland is 
Amphiregulin (Areg).  At puberty, estrogen induces Areg expression and production in 
epithelial cells.  The membrane-bound ligand is then cleaved by ADAM17 and freed to 
bind stromal EGFR.  Activation of EGFR in the stroma can stimulate MMP2 production, 
which promotes cell survival in the advancing TEB.  While ablation of the Pgr does not 
alter ductal elongation, it does attenuate tertiary side branching.  P4, acting through its 
receptor, is thought to promote tertiary branching through Wnt4 production.      
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 It has been shown that FGFR activation is critical for the proper formation of the 
mammary placodes during embryogenesis (Veltmaat et al. 2003).  Unfortunately, 
genomic deletion of the Fgfr2IIIb results in embryonic lethality, making it difficult to 
examine any adolescent or adult mammary gland defects as a result of receptor loss.  
Recently, Dr. Zena Werb’s laboratory used the Cre/LoxP system to generate a 
conditional Fgfr2IIIb-/- mouse (Lu et al. 2008).  Cre-mediated excision, driven by the 
MMTV promoter expressed in the mammary epithelium, occurred by 3 weeks of age in 
this model.  By 5 weeks of age, the mammary ducts in the mutant animals showed 
reduced branching, and this phenotype persisted throughout adolescent development.  
Closer examination of Fgfr2IIIb mutants revealed defects in TEB cell proliferation, and 
this same defect was observed during pregnancy-associated alveolar expansion.  It is 
likely that Fgf ligands, produced by the mammary stroma, influence proliferation of cells 
in the TEB to promote ductal outgrowth.   
 In the human, mammary gland development is quite poorly characterized and 
appears similar to that in the mouse, but some distinct differences have been reported.  
By 13 weeks of gestation, human fetuses have well defined mammary buds with few 
branches that are surrounded by dense mesenchyme (Tobon and Salazar 1974).  During 
the second trimester, the ductal structures have extended and branched further, but have 
not penetrated the subcutaneous adipose tissue.  By the third trimester, the epithelial 
ducts are distended with secretions and the cells contain cytoplasmic lipid droplets, a 
phenomenon that has not been reported in rodent models.  The structure of the mammary 
gland in humans can be characterized by morphological type and functional stage.  
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 There are 3 morphological types and 5 functional stages.  The early 
morphological type is characterized by simple structural formations and ducts, with 
advanced lobular structures and branched ducts described by later categories, and all 
three are present in the human mammary gland at birth.  Using criteria of the functional 
stages, it has been postulated that the human mammary gland develops advanced lobular 
structures during embryogenesis and that these structures acquire secretory activity, then 
undergo involution, similar to that observed following lactation.  Interestingly, in the 
human mammary gland, no differences are seen between males and females in 
morphological type or functional stage from birth until 2 years of age, and the ductal 
structures can vary greatly between individuals (Tobon and Salazar 1974; Anbazhagan et 
al. 1991).   
 In adolescent humans, mammary structural development is, again, highly 
variable, but in most subjects, the outer edges of the breast have developed lobular 
structures with multiple layers of epithelium.  One study investigated the molecular 
characteristics of the mammary cells in the fetus, infant, and adolescent (Naccarato et al. 
2000).  The authors found diffuse Bcl2 staining throughout development, indicating few 
apoptotic cells, and low ESR1/Pgr reactivity until puberty, when the level of nuclear 
receptor staining increased to about 50% of the epithelial cells.  In this study, cell 
proliferation was also examined and was found to be low during fetal and infant 
development, similar to what is seen in the mouse.  There was no mention of an 
association between Pgr staining and proliferating cells, which has been previously 
described in mouse mammary epithelium (Seagroves et al. 2000).     
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 The previous sections have described the importance of mesenchymal- or 
stromal-epithelial interactions in the specification, patterning, and growth of the mouse 
mammary gland, and these interactions are likely important for human development as 
well.  Factors present in circulation or produced locally by the mammary stroma act on 
the developing epithelial structures to promote growth, invasion, or differentiation.  The 
next sections will focus more on the epithelial cells, themselves, and how the functions 
they acquire make them unique to the mammalian species.       
   
Acquisition of Epithelial Cell Fate 
Identification of Mammary Stem Cells 
 Mammary gland differentiation is biphasic.  The first phase of differentiation 
occurs during embryonic development when, hypothetically, one mammary epithelial 
stem cell gives rise to progenitor cells that proliferate and acquire characteristics that 
make up the different components of the adult gland, including ductal, alveolar, and 
myoepithelial cells.  Later, during pregnancy, the epithelium expands to fill the 
mammary fat pad and specialized alveolar epithelial cells acquire the ability to produce 
milk.  This phase of differentiation will be discussed later.  The two levels of 
differentiation are not exclusive, as stem cells are required to participate in expanding 
the adult mammary gland during each pregnancy. 
 The existence of mammary stem cells was first determined in 1959(Deome et al. 
1959).  Epithelium from adult donor mice was harvested and transplanted into the fat 
pad of juvenile recipient mice once cleared of its epithelium (Deome et al. 1959).  These 
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studies showed that a small amount of epithelium from an adult could reconstitute a 
functional mammary gland and also could be serially transplanted several times.  Since 
then, many mammary gland biologists have used the technique to analyze the potential 
of epithelial cells to reconstitute a mammary gland under varying conditions.  This 
technique has been especially useful to elucidate the role of some genes in mammary 
gland development when deletion of both alleles causes mid- to late-embryonic lethality, 
or to determine if the effect of gene loss originates in the stromal or epithelial 
compartments.  In 1988, Drs. Gil Smith and Dan Medina performed similar studies to 
evaluate the outgrowth potential of different portions of the mammary gland from mice 
at varying stages of development.  They showed that any portion, i.e. end bud, tertiary 
duct, primary duct, or alveolar structure, could efficiently reconstitute a mammary gland 
in 6 weeks unless the donor female was lactating (Smith and Medina 1988).  In that case, 
the fat pad did not completely fill with epithelium unless the animal became pregnant.  
These results suggested that mammary stem cells exist in all portions of the mammary 
tree at all stages of development, and that cell proliferation is slower if the cells are 
harvested from a lactating female.  They went on to identify a morphologically distinct 
cell located throughout the mammary gland that was hypothesized to be a mammary 
stem cell.  This large pale-staining cell was thought to have low oxidative metabolism 
and mitotic potential in vivo.  The number of these cells was reduced in the lactating 
mammary gland.    
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Isolation of Mammary Stem Cells According to Marker Expression 
 For the past several decades, mammary gland biologists have tried to isolate the 
elusive mammary stem cell using cell sorting techniques followed by limiting dilution 
and serial transplantation, which are the functional assays of mammary stem cell 
activity.  In 2006, experiments were describes in which a fully functional mammary 
gland was produced from a single stem cell in a cleared mammary fat pad (Shackleton et 
al. 2006).  The authors evaluated these cells using markers previously identified in other 
tissue types.  CD24, or heat stable antigen, is a cell surface-bound protein first identified 
in B cells.  Later, it was found to be highly expressed in tumors of various origins, 
including those found in the mammary gland.  In the adult mouse mammary epithelium, 
CD24 expression can be divided into 3 groups:  absent, low, and high.  Of these groups, 
cells with low CD24 expression (CD24low) were most likely to reconstitute a mammary 
gland when transplanted to a cleared fat pad (Regan and Smalley 2007).  Sorting cells 
using CD24 and CD29, or beta1-integrin, Dr. Visvader’s lab showed that one cell from 
the CD29high/CD24+ (corresponding to CD24low described elsewhere) was capable of 
complete mammary gland formation in 6 of 102 cases.  The authors further showed that 
the CD29high/CD24+ population of cells also showed high expression of CD49f, or 
alpha6-integrin.  Both CD29 and CD49f are basal epithelial cell markers and it has been 
hypothesized that stem cells exist in the basal compartment of the mammary gland 
(Taddei et al. 2008). 
 Earlier work focused on the Side Population or SP cells that were revealed after 
staining with Hoescht 33342 dye and sorting (Alvi et al. 2003).  These cells expressed 
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high levels of Abcg2, also known as the Breast Cancer Resistance Protein-1 (BCRP-1).  
Members of the ABC transporter family participate in efflux of compounds from cells, 
and of the Hoescht dye; however, the work published in Nature in 2006 did not find a 
correlation between mammary stem cells and SP cells and lately, there have not been 
many studies reported that focus on this population.  Figure 3 depicts a diagram of 
cellular differentiation in the mammary gland.  
 
 
    
 Figure 3.  Cellular Differentiation in the Mouse Mammary Gland.  Schemiatic drawing of the progression 
of mammary stem cell differentiation and associated marker expression.  Long-term stem cell (LT-SC) and 
transit amplifying stem cell (TA-SC).  Courtesy of Mike Lewis, Ph.D., Baylor College of Medicine  
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  Although sorting primary mammary epithelial cells based on these markers can 
provide enrichment for certain populations, the identifiers are just markers.  Some 
groups have begun to elucidate genes associated with marker variation or with stem cells 
in other tissue types, providing more information on the inner workings of the mammary 
stem cell.  In 2007, Ginestier and colleagues evaluated aldehyde dehydrogenase 1 
(ALDH1) activity and expression as an indicator of multipotency in the mammary gland 
(Ginestier et al. 2007).  ALDH1 is a detoxifying enzyme that catalyzes the oxidation of 
aldehydes.  The enzyme is proposed to play a role in stem cell differentiation by 
converting retinol to retinoic acid.  Additionally, ALDH1 activity is high in 
hematopoietic and neural stem cells from mice and humans.  Ginestier et. al. showed 
that, in humans, ALDH1 positive cells make up approximately 8% of the total epithelial 
population and are located in the terminal ductal lobular units (TDLUs), similar to 
mouse TEBs, where mammary stem cells are proposed to reside.  Using a humanized fat 
pad transplantation model, the investigators showed that only ALDH1 positive cells 
were capable of mammary outgrowth formation.    
 In the mature adult female mouse, approximately 30-40% of mammary luminal 
epithelial cells express ESR1 and Pgr.  These nuclear receptor positive cells are located 
throughout the ductal network and are hypothesized to stimulate proliferation of 
adjacent, receptor negative cells, by a paracrine mechanism.  In young nulliparous 
animals, however, most of the luminal epithelial cells express ERα and PR.  Recently, 
Dr. Seagroves and colleagues evaluated the effect of C/ebpb loss on mammary 
development (Seagroves et al. 2000).  In that study, they showed that in the absence of 
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C/ebpb, the distribution of Pgr positive cells resembles that found in an immature 
mammary gland.  They postulated that uniform expression of hormone receptors in 
immature nulliparous females prevents hormone-dependent alveolar development prior 
to the completion of ductal elongation.  Once the ductal network is established, alveolar 
expansion is appropriate and hormone receptor expression adopts a more non-uniform 
pattern.  In mature C/ebpb-/- glands, steroid receptor expression remained uniform and 
did not adopt the chimeric pattern found with increasing age.  The authors hypothesized 
that, when the entire duct was analyzed, uniform steroid receptor expression reflected 
globally, a less differentiated gland.  Their data suggested that C/ebpb expression and 
activity is required for proper maturation of the mammary luminal epithelial cells during 
development.    
 Some genes associated with cell cycle progression or DNA damage responses 
have been shown to be involved in mammary epithelial cell differentiation.  BRCA1, 
mutated in some cases of breast cancer, is required for the differentiation of mouse 
(Kubista et al. 2002) and human (Furuta et al. 2005) mammary epithelial cells.  In 
addition, human mammary tissue from individuals with germline BRCA1 mutations has 
a higher proportion of ALDH1 positive cells, presumed to be undifferentiated 
progenitors (Liu et al. 2008).  Retinoblastoma1 (Rb1), a well-characterized tumor 
suppressor, is induced during mid-pregnancy in the mammary gland, and has an 
interesting role in mammary epithelial cell differentiation.  Embryos lacking Rb1 die in 
utero, but mammary buds can be transplanted and their growth evaluated (Robinson et 
al. 2001).  While there are no defects seen in ductal outgrowth or secretory 
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differentiation, which takes place during mid-pregnancy, the possibility remains that 
Rb1 participates in regulating the function of the gland during lactation.  This step of 
development cannot be evaluated in a transplant model and a study published on a 
conditional Rb1 mutant model only discussed tumor formation.  When a constitutively 
active form of Rb1 is expressed in the mammary epithelium, the gland displayed 
reduced ductal growth, precocious lactogenic differentiation, and interestingly, tumor 
formation after a long latency, likely due to sustained epithelial cell survival (Jiang and 
Zacksenhaus 2002).  From these studies, it is clear that some genes involved in the 
commitment of mammary stem cells to a luminal fate are also involved in the 
differentiation that takes place beginning in mid-pregnancy.  The next sections will 
describe that stage of mammary development in detail. 
  
Pregnancy and Lactation 
Secretory Differentiation 
 The open architecture of the nulliparous mammary gland allows space for the 
expansion of the epithelium that takes place during pregnancy.  With each estrus cycle, 
small tertiary branches form along the ducts that will eventually give rise to functional 
alveolar structures.  Hormones, such as P4 and Prolactin (Prl), are released into 
circulation in early pregnancy and promote proliferation of luminal epithelial cells and 
lobule formation.  Functional differentiation of the mammary gland is divided into 
stages.  Lactogenesis I, also known as secretory differentiation, takes place during the 
later part of pregnancy in most mammals and is characterized by elevated expression of 
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milk protein genes and formation of lipid droplets in the alveolar epithelium.  These 
effects were documented in cows and rabbits in 1933 and 1950 respectively (Folley 
1956).  Lactogenesis II, or secretory activation, occurs at or near parturition and is 
associated with abundant milk production and secretion, and other changes in alveolar 
epithelial cells that are discussed below.   Various circulating and local factors work 
together to stimulate the synthesis and expulsion of milk throughout lactation.  
 Progesterone and Prolactin are two of the most important hormones involved in 
proper pregnancy-associated development and function of the mammary gland.  Two 
isoforms of Pgr are expressed in the mammary epithelium (Aupperlee et al. 2005).  PgrA 
and PgrB, both encoded by the same gene, have different expression profiles during 
ductal morphogenesis.  PgrA is most highly expressed in luminal cells during virgin 
development, but PgrB expression increases at midpregnancy, while neither isoform is 
detectable during lactation.  Complete ablation of both Pgr isoforms results in severe 
reproductive and hormonal abnormalities, making it difficult to assess the effect of Pgr 
loss in the mammary epithelium specifically.  Isoform specific knockout mouse studies 
have revealed that PgrB is required for proper alveolar expansion in the pregnant animal 
(Mulac-Jericevic et al. 2003).  Females deficient in PgrB expression were able to lactate; 
however, the pups they nursed were malnourished and smaller than those fed by control 
animals.  Gross examination of mammary glands from PgrB null mice revealed fewer, 
but properly developed alveoli.  It was also found that expression of receptor-activator of 
NFκB signaling ligand (RANKL), thought to play a role in pregnancy-associated 
epithelial cell proliferation, was decreased in PgrB null mice.  The authors concluded 
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that P4 exerts its effects in the mammary epithelium during pregnancy by activating 
PgrB, which promotes production and secretion of RANKL.  By activating RANK on 
adjacent cells, RANKL stimulates activation of Cyclin D1 and proliferation, leading to 
the formation of numerous alveoli.  Recently, a study was published that evaluated, in 
detail, the pattern of PgrA and PgrB expression throughout mouse mammary 
development (Aupperlee et al. 2005).  It was determined that PgrB was not expressed 
until day 14 of pregnancy, well after alveoli have formed.  It is possible, then, that PgrA 
mediates the initial burst of proliferation seen during the first week of pregnancy, as that 
is the predominant isoform expressed in the epithelium, and that PgrB can compensate 
for the loss of PgrA in isoform-specific knockout mice.    
 Prolactin plays an important role in alveolar formation and secretory 
differentiation, in addition to its necessity for sustained lactation and alveolar cell 
survival.  The effect of anterior pituitary hormones on the mammary gland was 
investigated in 1928 and 1930 by Stricker, Grouter, and Strausburg.  Extract from this 
tissue was shown to have lactogenic effects in rats (Folley 1956).  In addition, A. T. 
Cowie performed hypophysectomies on intact, lactating rats at four days post-partum 
(Folley 1956).  He showed that, without the pituitary gland, only 4% of pups survived to 
weaning age.  Several separate studies, done in the mid- to late 1940s, showed that 
purified Prl injected into the rabbit mammary gland induced localized lactation, 
indicating the hormone’s direct effect on the mammary epithelium (Folley 1956).  
Prolactin, which we now know is secreted from the anterior pituitary gland, acts by 
binding to its receptor (Prlr) that exists in a short and long form.  Activation, and 
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subsequent dimerization, of both isoforms of Prlr leads to Jak2 phosphorylation, but only 
activation of the long form can result in phosphorylation and nuclear translocation of 
Stat5a.  Activated Stat5a binds γ-interferon activation sites (GAS) with the sequence 
TTCNNNGAA, in the promoters of target genes including Wap and Csn2.  Complete 
ablation of the Prlr leads to infertility, among other problems (Ormandy et al. 1997).  
Analysis of Prlr+/-females, though, revealed a defect in pregnancy-associated lobulo-
alveolar formation and reduced pup survival.  This effect was attenuated with increasing 
age of the female at first pregnancy, and was almost completely reversed by the second 
lactation cycle.   
 Further characterization of Prlr function in the mammary gland took place two 
years later.  Cathrin Brisken and colleagues closely examined the mammary glands of 
Prlr+/- females and also found that those with difficulty nursing pups had poorly 
developed alveolar structures (Brisken et al. 1999).  When mammary rudiments from 
Prlr-/- females were transplanted into cleared recipient fat pads, pregnancy-associated 
outgrowths were minimal as was milk production.  These studies confirmed that Prl, 
acting through its receptor in the mammary epithelium, is required for alveolar 
outgrowth and function of the mammary gland during pregnancy and lactation.   
 Confirmation of the Prl signaling cascade was achieved by performing loss-of-
function studies on Jak2 and Stat5a.  Deletion of Jak2 in the mammary epithelium 
resulted in attenuated alveolar formation and Wap production during lactation.  
Additionally, using a LacZ reporter transgenic mouse model, investigators showed that 
Jak2 was required for survival of differentiated alveolar epithelial cells (Wagner et al. 
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2004).  Genomic ablation of Jak2 resulted in embryonic lethality; however, transplanted 
mammary rudiments from these animals failed to respond to treatment with E2 and P4, 
which mimicks pregnancy effects, by forming alveoli.  Two markers routinely used to 
assess differentiation of mammary epithelial cells are Nkcc1 and Npt2b.  Nkcc1 is 
expressed in the developing virgin and declines during pregnancy.  Conversely, Npt2b is 
upregulated during late pregnancy and lactation.  Analysis of marker expression in   
Jak2-/- transplanted glands revealed sustained Nkcc1 expression and a lack of Npt2b 
upregulation at the end of pregnancy (Shillingford et al. 2002).  In the absence of Stat5a, 
similar defects were observed (Liu et al. 1997).  Stat5a-/- mothers could not nurse young 
and their mammary glands did not expand during the later stages of pregnancy.  
Examination of the few alveolar cells that formed revealed lipid droplet accumulation, 
indicating an increase in metabolic activity normally associated with secretory 
differentiation; however, the cells never acquired secretory activity.  Gene expression 
analysis showed a defect in Wap production, similar to that identified with Jak2 deletion.  
Together, these studies highlight the importance of the Prlr/Jak2/Stat5a signaling 
cascade in alveolar formation and secretory activation in the mammary epithelium 
during late pregnancy and lactation.   
 
Secretory Activation 
 Secretory activation takes place at parturition as a result of P4 withdrawal.  In 
mice, P4 is produced by the ovaries throughout pregnancy and declines shortly before 
the birth of the pups.  In humans, the placenta is responsible for the circulating P4 during 
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much of pregnancy, and placenta removal is necessary for onset of abundant milk 
production.  At parturition, Prl levels surge leading to augumented production of milk 
proteins and other components.  In addition to its role in alveolar formation, Prl, released 
from the brain in response to suckling, can act by signaling through its receptor to 
promote cell survival via induction of IGF1 and subsequent inhibition of IGFBP5, which 
is involved in involution after pup removal (Flint et al. 2006).   
 In addition to protein, lipids, lactose, ions, and water are secreted from alveolar 
epithelial cells, and the composition of these constituitents varies across mammalian 
species.  In humans, for example, only 5% of breast milk is composed of lipid, while 
mice produce milk that contains 25-30% fat.  Depending on the diet, the fatty acid 
composition may vary, but the percent of lipid remains consistent (Rudolph et al. 
2007b).  Secretory activation is characterized by copious milk production, upregulation 
of lipogenic enzymes, down regulation of fatty acid beta-oxidation enzymes, closure of 
epithelial tight junctions, and polarization of cellular organelles.  Proteins, water, lactose, 
and calcium are released from alveolar epithelial cells through an exocytotic pathway.  
Lipids are synthesized in the epithelial cell and aggregate into a unique membrane-
encased structure, called a milk fat globule, which is secreted by a budding process.  
Other transport pathways exist for the movement of some proteins, ions, and small 
molecules, such as glucose and amino acids.  Closure of the tight junctions during 
lactation prevents paracellular transport, normally used by low molecular weight 
substances and large solutes to travel between cells, and back and forth from the 
interstitial space to the lumen of the duct.    
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 The proteins produced during secretory differentiation and lactation include 
members of the Casein family, whey acidic protein (Wap), WDNM1, and alpha-
lactalbumin.  Of these, the milk protein, beta-Casein, is the most widely studied and its 
regulation the best characterized.  Both in vivo and in vitro, hormones such as insulin, 
glucocorticoids, and Prl are known to induce transcription of the Csn2 gene.  In 1993, 
Happ and Groner showed that mammary gland factor (MGF now known as Stat5a) was 
the nuclear factor that responded to hormones to induce Csn2 transcription (Happ and 
Groner 1993).  The HC11 cell line is an excellent model to use for studying the 
regulation of Csn2, as the gene is one of the only physiologically relevant milk protein 
genes expressed upon Prolactin treatment.  In addition to Stat5a, C/ebpb, GR and YY1 
have all been shown to bind the Csn2 promoter and play positive or negative regulatory 
roles in transcription (Kabotyanski et al. 2006).  Mutational analyses performed on the 
rat Csn2 promoter identified C/ebp binding sites that were critical for both basal and 
lactogenic hormone-induced activation of Csn2 (Doppler et al. 1995).  Conversely, the 
nuclear factor, YY1, was shown to be important in the negative regulation of Csn2 
expression and was dissociated from the Csn2 proximal promoter upon addition of 
Stat5a (Meier and Groner 1994).  ChIP assays, performed on samples isolated at specific 
timepoints during HC11 cell differentiation, have showed that within 15 minutes of Prl 
stimulation, Stat5a is recruited to GAS sites in the Csn2 promoter (Kabotyanski et al. 
2006).  In addition to various milk proteins, the alveolar epithelial cells synthesize and 
secrete large amounts of lipid throughout lactation (Rudolph et al. 2007a).  Milk lipid, 
secreted in the form of triglycerides (TG), generally comes from three sources: dietary 
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fat, mammary stromal adipocytes that regress beginning in pregnancy, and de novo 
lipogenesis that relies glucose and other macromolecular resources.  The genes 
responsible for TG synthesis begin to increase at mid-pregnancy, explaining the 
appearance of cytoplasmic lipid droplets (CLDs) in the mammary epithelium at this 
stage.  At parturition, there is a drop in expression of fatty acid beta-Oxidation genes and 
an increase in lipogenic enzyme mRNA expression.  This shift in mRNA expression was 
proposed to be regulated by a balance in PPARγ and LXR activity and subsequent 
induction of SREBP1c.  This bHLH family member also plays a role in the activation of 
lipogenesis in the 3T3-L1 mouse preadipocyte line.  Interestingly, in the mammary 
glands of mice fed high fat chow, SREBP1c induction was minimal, as was expression 
of its target genes.  This indicates that SREBP1c and its downstream targets are 
responsible for de novo lipogenesis when dietary fat sources are unavailable.  
Additionally, in mice on a high fat diet, the adipose compartment of the mammary gland 
undergoes minimal regression, while in mice fed normal (i.e. 4% fat) chow, adipocytes 
are completely de-lipidated by parturition.  
 
Involution 
Natural Loss of Function 
 A normal mouse lactation period lasts 21 days.  According to the lactation curve, 
the maximum secretory ability of the gland is reached nearly 11 days before the pups are 
old enough to be weaned (Hanrahan and Eisen 1970).  The decline in secretory ability of 
the mammary gland is referred to as secretory diminution (Hadsell et al. 2006), and has 
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been hypothesized to be due to several things.  Secretory cell aging, proposed in 1989, is 
thought to play a role in the failure of lactation, although this theory has not been 
confirmed (Hadsell et al. 2007).  In mice, activity of the mitochondrial cytochrome C-
oxidase, or Complex IV of the electron transport chain, increases until day 10 of 
lactation and then begins to decline (Hadsell et al. 2007).  Forced involution in rats has 
been associated with increased oxidative damage to mitochondrial DNA (Esteve et al. 
1999), while in mice, oxidative DNA damage begins to increase during the gain-of-
function phase of lactation (Hadsell et al. 2006).  Although these studies suggest that 
alveolar epithelial mitochondria experience a loss of function associated with oxidative 
damage, there are no reported associations between this stress and changes in 
mitochondrial function during prolonged lactation or involution.  Additionally, it is 
unclear if secretory diminution is centrally or peripherally mediated, but likely involves 
the interplay of the stromal and epithelial compartments in the mammary gland.   
 Cross-fostering experiments in both rats and mice have been shown to prolong 
the secretory ability of the alveolar epithelial cells by ensuring complete and frequent 
milk removal from the gland (Hadsell et al. 2006).  It is likely that pup behavior, such as 
eating solid food, and leaving the nest to explore the cage, causes them to suckle less 
than if they were younger and contributes to the natural loss of function.  Additionally, 
the mother may encourage less nursing after the pups grow teeth.   
 To avoid the sporadic involution of different lobules as a variable in studying 
involution, many investigators use a forced-weaning model.  This involves normalizing 
the litter sizes to approximately 8 pups and allowing the mother to lactate for 10 days 
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before the pups are removed and the glands are harvested.  This model, combined with 
several studies reporting genes associated with failed lactation, has led to the discovery 
of important regulators of involution.  There is an overwhelming abundance of studies 
that report either accelerated or delayed involution when various genes are manipulated, 
but only a few factors have central roles.  Those factors will be discussed in the next 
section.   
 
Regulation of Mammary Involution 
 Using the forced-weaning model, it was revealed that involution occurs in two 
phases:  an immediate, reversible phase, induced by the build up of milk in the alveoli, 
and characterized by a small amount of apoptotic epithelial cells that have been shed into 
the lumens, and a later, irreversible phase that involves complete gland remodeling by 
MMPs, and lipid accumulation in the stromal adipocytes (Lund et al. 1996).  The first 
phase lasts 24-48 hours, and during this time, circulating prolactin levels begin to 
decrease.  It has been shown that Prl-mediated Stat5a activation is important for the 
function and survival of the alveolar epithelial cells (Flint et al. 2006).  Several mouse 
models have revealed that LIF production by epithelial cells, acting through its receptor 
and Jak activation, causes phosphorylation of Stat3.  Following Stat3 activation, C/ebpd 
and IGFBP5 are induced, and lead to upregulation of members of the pro-apoptotic Bcl2 
family including Bak and Bax.  Phosphorylation and activation of Stat5a ceases, and 
expression of anti-apoptotic genes, such as Bcl2a1 and Bcl2l2, is reduced.  Mice with 
deficiencies in LIF, Stat3, and C/ebpd all share similar phenotypes, experiencing delayed 
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involution characterized by sustained distention of alveoli with milk, low levels of active 
Caspase-3, and maintenance of alveolar structures (Chapman et al. 2000; Humphreys et 
al. 2002; Kritikou et al. 2003; Thangaraju et al. 2005).  IGFBP5 has been shown, in wild 
type glands, to bind and sequester IGF1, which promotes epithelial cell survival, in 
addition to its role in adolescent development.  In the absence of LIF and Stat3, 
involution does occur, although it is delayed.  Under these circumstances, cell death is 
mediated largely by p53 activity.   
 Three to four days after pup removal, expression of MMP3 and C/ebpb increases 
in the mammary gland.  Currently, there is very little literature on the role of C/ebpb 
during mammary involution.  It is worth noting that each of the studies mentioning the 
association of C/ebpb with mammary involution did so by evaluating whole mammary 
gland lysate by either western blot, northern blot, or PCR analysis (Raught et al. 1995; 
Gigliotti and DeWille 1998; Gigliotti and DeWille 1999; Thangaraju et al. 2004).  
Because C/ebpb is important for adipogenesis, and mammary epithelial regression 
during involution happens concurrently with differentiation of adipocytes in the stroma, 
it is possible that the upregulation of C/ebpb during involution actually takes place in the 
mesenchymal comparment and that it does not have a critical role in alveolar 
disintegration.   
 MMP3, or stromelysin 1, participates in degradation of the basement membrane 
and has been found to be primarily produced by stromal cells immediately adjacent to 
alveoli (Lund et al. 1996).  Several studies have revealed a requirement for basement 
membrane integrity, and association with epithelial cells in lactogenic differentiation and 
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function (Barcellos-Hoff et al. 1989; Chen and Bissell 1989; Streuli et al. 1991).  Using 
teat-sealing experiments, which allow the elucidation of pathways involved in mammary 
involution in the presence of circulation lactogenic hormones, Talhouk and colleagues 
determined that TIMP production prevents MMP expression during the initial, reversible 
stage of involution (Talhouk et al. 1992).  In addition, transgenic mice expressing 
MMP3 in the mammary epithelium, under the control of a Wap promoter expressed 
during lactation, had smaller alveoli and experienced early involution (Talhouk et al. 
1992).  Together, these studies highlight the mammary gland as an excellent model to 
evaluate normal processes associated with cell death and tissue remodeling.   
 
A Short History of Sim2 
 Singleminded-2 (Sim2) is a member of the bHLH-PAS family of transcription 
factors.  PAS proteins influence transcription of target genes as heterodimers and 
recognize consensus response elements in gene regulatory regions.  Sim2 is one of two 
mammalian homologs of Drosophila Singleminded (dsim), which is required for proper 
CNS development in fly embryos.  Located in the Down Syndrome Critical Region 
(DSCR) of HSA21, Sim2 is thought to influence some of the developmental 
abnormalities associated with Down Syndrome (DS).  Our research has focused on SIM2 
as a potential mammary tumor suppressor based on a study published in 2000 examining 
the solid tumor occurrence in individuals with DS (Hasle et al. 2000).  Of the 2800 
people surveyed in the study, the investigators expected 7 cases of breast cancer and 
observed none.  Thus, previous studies performed in our lab have evaluated the 
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relationship between SIM2 and cancer cell growth, invasion, and metastasis.  Until we 
began our investigation, it was not determined if Sim2 had a role in normal development 
and differentiation of the mammary gland.   
  
Drosophila Singleminded 
 Loss-of-function studies performed in Drosophila have revealed a role for dsim 
in establishing the fate of the central midline cells, which are the first to be specified 
during embryonic neurogenesis.  In the absence of dsim, the midline cells degenerate, 
and other precursors lack expression of ventral epidermal, and lateral neuronal markers 
(Chang et al. 2001).  Conversely, ectopic expression of dsim in mutant embryos rescues 
CNS defects and causes non-midline cells to adopt a midline fate (Menne et al. 1997).   
Additionally, the factors produced by the midline cells, and thus by dsim activity, are 
required for the specification and differentiation of lateral neural cells and for expression 
of dorsoventral patterning genes during embryonic neurogenesis.  Later in 
embryogenesis, instructive signals from midline cells are thought to influence 
differentiation of mesodermal cells, which eventually adopt a dorsal median fate.  While 
dsim expression is restricted to the single row of midline cells during early development, 
its role in activating transcription of spitz class genes is necessary to achieve the precise 
gradient of secreted, instructive factors that ultimately influence the patterning and 
differentiation of multiple cell types in the Drosophila CNS.    
 In Drosophila, dsim forms a heterodimer with tango (tgo), homologous to 
mammalian ARNT, and this association has been shown to require the PAS domain in 
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the N-terminal region of the dsim protein, while the basic domain is required for 
association of the dsim/tgo heterodimer with DNA response elements.  A consequence 
of inhibiting dsim/tgo heterodimerization was observed in dsim mutant flies.  Using a 
temperature-sensitive allele, which substitutes a phenylalanine for serine in the HLH 
domain of dsim, investigators showed that the mutant flies could only walk in circles and 
had reduced fertility.  They found that the dsim/tgo heterodimer is required for proper 
formation of the portion of the CNS responsible for walking behavior, and to correctly 
pattern genital discs and the anal pad anlagen (Pielage et al. 2002).  A separate study, 
evaluating mutations of dsim binding sites in target genes, revealed that dsim acts as a 
transcriptional activator, and that association of dsim with DNA was not required for 
repression of transcription, indicating that it inhibits gene expression by activating 
repressors (Estes et al. 2001).   
 Outside of the CNS, dsim is necessary for the migration and eventual fusion of 
mesectodermal cells with ventral muscle fibers (Zhou et al. 1997).  In addition, left-right 
asymmetry was not established in the Drosophila gut in the absence of dsim expression, 
which is reminiscent of the CNS phenotype observed under the same circumstances.  
Based on data showing a requirement of dsim expression and transcriptional activity for 
the formation of midline cells, and on the necessity of secreted factors produced by 
midline cells for the proper patterning and differentiation of the entire Drosophila CNS, 
dsim has been called the “master” regulator of neurogenesis in this organism (Nambu et 
al. 1990).  This title is somewhat misleading, as it is clear that the requirements for dsim 
activity extend beyond the Drosophila CNS cell types, and in the next sections, I will 
 36
describe the role singleminded proteins play in the development and function of multiple 
structures in higher species.       
 The singleminded (sim) gene has been identified and cloned in xenopus and 
zebrafish.  In these organisms, sim is expressed in the developing CNS during 
embryogenesis.  In adult zebrafish, as in mammals, there are two homologs of dsim, 
Sim1 and Sim2.  A requirement for SIM1 in the development of isotocin cells, part of 
the preoptic-neurohypophysial system, has been established (Eaton and Glasgow 2006).  
Sim2 is expressed in muscle, heart, liver, eyes, gills, and intestines, but whether or not 
Sim2 is required for development of these structures and for differentiation of the CNS, 
as it is in Drosophila, is yet to be determined (Coumailleau et al. 2000; Wen et al. 2002). 
  
Mammalian Singleminded Proteins 
 In 1995, investigators published the identification of one human homolog of dsim 
in the DSCR of Chromosome 21 (Chen et al. 1995).  Two years later, two homologs of 
dsim were cloned using exon trapping.  In addition to Sim2, this group identified Sim1, 
located on HSA6 (Chrast et al. 1997).  In this same study, the authors reported the 
production of a short isoform of Sim2, called Sim2s, due to alternative splicing.  The two 
isoforms of Sim2 are identical except for the lack of a proline/alanine domain in the C-
terminal region of Sim2s (Chrast et al. 1997).  In mice, screening of a cDNA library 
from E11.5 embryos revealed a mouse homolog of dsim located on MMA16, now 
known to be mouse Sim2 (Yamaki et al. 1996) (Figure 4).  Our lab first identified the 
short isoform of mouse Sim2, called Sim2s, which is produced by a similar mechanism 
 37
as the human isoform (Metz et al. 2006) (Figure 5).  The mouse and human Sim2 
proteins act as transcriptional repressors, contrary to dsim, but both short isoforms have 
variable activity depending on the promoter and cell type (Metz et al. 2006).   
 
                                     
                                  
 
 
Figure 4. Location of Sim2 in Humans and Mice.  Schematic drawing of human chromosome 21 
and mouse chromosome 16 showing location of Sim2 genes.  Adapted from Chrast et. al., 2000.  
 Several studies have been performed, using mouse models, to elucidate the 
involvement of Sim2 in CNS development due to its critical chromosomal location.  The 
initial identification and characterization of mammalian Singleminded genes was done in 
1995 and early 1996 by several groups.  In the May 1995 issue of Nature Genetics, Chen 
and colleagues first reported the discovery of 6 exons with sequence homology to dsim 
located on HSA21, in an attempt to isolate genes associated with the DSCR (Chen et al. 
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1995).  In the summer of 1995, Muenke and colleagues published a study on 
holoprosencephaly.  While they did not find an association between HSA21 and 
holoprosencephaly, they did mention the existence of 2 human homologs of dsim, 
located on HSA6 and 21 (Muenke et al. 1995).  At the same time, Dahmane and 
colleagues reported the use of exon trapping to identify a portion of the DSCR with 
sequence similarity to dsim and detected 2 transcripts by northern blot analysis in the 
human fetal kidney (Dahmane et al. 1995).  In this study, the authors evaluated 
expression of Sim2 by ISH in developing rat embryos and in 16 week old human fetuses.  
The strongest expression of Sim2 was found in the skull and facial primordia, and also in 
the vertebral body and ribs of E13-E15 rats, while the CNS was strongly labeled in the 
region of the basal hypothalamus.  In human fetuses, similar regions as seen in the rat 
embryos expressed Sim2.  In 1996, the same group that originally reported the 
identification of a dsim homolog on HSA21 cloned a singleminded gene from a mouse 
E11.5 cDNA library, to begin to analyze the structure of the protein (Yamaki et al. 
1996).   
 
 
  
bHLH PAS1 PAS2 HST P/T P/S P/A P/A P/A 657 aa
bHLH PAS1 PAS2 HST P/T P/S P/A
Sim2
Sim2s 579 aa
bHLH PAS1 PAS2 HST P/T P/S P/A P/A P/A 667 aaSIM2
bHLH PAS1 PAS2 HST P/T P/S P/A 570 aaSIM2s
 
 
 
 
Figure 5.  The Mammalian Singleminded Proteins.   Schematic drawing of human and mouse Sim2 
proteins with conserved and variable domains.  Adapted from Chrast, et. al., 1997.    
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They determined that the amino terminal region of the mammalian singleminded protein 
showed similarity to dsim, the AHR, PER, and ARNT, but the carboxy-terminus did not 
show any homology to the Drosophila isoform.  Based on analysis of the protein 
structure, it was concluded that the Sim homolog identified in this study was identical to 
the Sim2 isoform that was reported previously.  Finally, in 1997, both human homologs 
of dsim, Sim1 and Sim2 were cloned (Chrast et al. 1997).    
 With the discovery of two mammalian homologs of dsim, Sim1 and Sim2, and 
the localization of Sim2 to HSA21 and a syntenic region in MMA16, came several 
studies evaluating the possibility that SIM2 was involved in the developmental 
abnormalities and mental retardation associated with the DS population.  The Fan 
Laboratory initially generated a construct to use for disruption of Sim2 expression 
(Goshu et al. 2002), but Shamblott and colleagues published the first study examining 
the consequence of Sim2 ablation on mouse embryonic development (Shamblott et al. 
2002).  Although Sim2-/- pups were born in the proper Mendelian ratio, none survived to 
weaning age.  Close examination of Sim2-/- pups revealed stomachs devoid of milk, and 
instead, full of air.  Most had severely cleft palates, characterized by decreased cell 
density and a high composition of hyaluronan (HA) in the ECM.  Analysis of HA 
Synthetase expression revealed a significant increase with the loss of both Sim2 alleles, 
as compared to heterozygote and wild type animals.  On the contrary, the study 
published by Goshu and colleagues described a slightly different phenotype of the Sim2-
/- mice, originally generated by another group (Goshu et al. 2002).  As reported 
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previously, Sim2-/- mice died shortly after birth.  In disagreement with the previous 
study, reporting cleft palates and aerophagia associated with Sim2 loss, these 
investigators discovered abnormally developed ribs, intercostal muscles, and diaphragms 
in Sim2 mutants.  In fact, they reported that in both wild type and mutant pups, the palate 
was properly formed and joined at the midline.  The defects in the muscle and rib 
development found in mutant animals were presumably responsible for the respiratory 
distress and cyanosis observed at birth and shortly before death.  Regardless of 
discrepancies in the literature, the early lethality of Sim2-/- mice eliminates this model for 
the use of studying behavioral changes resulting from Sim2 disruption.  Generation of 
trisomy 16 and Sim2-overexpressing mice, however, helped overcome this obstacle.   
 Evaluation of mice with complete trisomy of MMA16 was reported in 1985, but 
these animals die in utero, making it difficult to study behavior and full CNS 
development (Epstein et al. 1985).  Two mouse models, each with partial trisomy of 
MMA16 that includes the region homologous to the DSCR on HSA21, have been 
generated and their behavior evaluated, in an attempt to establish models of Down 
Syndrome.  The Ts65DN mouse was created first, and was found to have reduced 
memory and learning behavior as judged by performance in a 12-arm radial maze, to 
have spontaneous locomoter hyperactivity, and low performance in a Morris Water 
Maze (Reeves et al. 1995; Demas et al. 1998).  It has been suggested that locomoter 
hyperactivity is a non-specific indicator of abnormal CNS development, and the 
reduction in performance on various learning tasks suggests partial trisomy of 
Chromosome 16 somehow influences communication between regions of the CNS.  In 
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1998, quite by accident, Sago and colleagues derived another partial trisomy 16 mouse 
while attempting to generate a Sod-/-  allele.  This mouse carries an extra copy of a 
slightly smaller DSCR than the one described previously.  Called Ts1Cje, this mutant 
also showed impaired performance in the Morris water maze (Sago et al. 1998).  Neither 
model is described as having abnormally developed facial or limb structures.  It can be 
presumed that both mouse models described above have three copies of Sim2 as a result 
of partial trisomy 16; however, in neither study did the investigators examine expression 
of the gene or production of the protein.  In 1999, Ema et. al. created a transgenic mouse 
overexpressing Sim2 under control of the chicken Actb promoter (Ema et al. 1999).  This 
study revealed mild deficits in contextual fear conditioning and, interestingly, in the 
Morris water maze task, associated with Sim2 overexpression.  Aside from the reduced 
performance on various behavioral tasks, the authors also reported the expression of 
Sim2 in wild type adult mouse skeletal muscle, kidney, lung, stomach, thalamus, 
hippocampus, and amygdala.  Two other Sim2-overexpressing mouse models were 
generated in 2000, bearing one or two additional copies of the gene, contrary to the 
model described in 1999 that used a chicken Actb promoter to drive transgene 
expresison (Chrast et al. 2000).  While the investigators of the former model reported 
reduced fear responses and learning impairments, those results could not be reproduced 
in this study.  The authors did report a higher tolerance of pain in the transgenic mice 
and noted reduced social behavior in female mice, but attributed the learning deficits of 
the mice in the first study to the artificial levels of Sim2 in that model.  Taken together, 
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these data indicate that overexpression of Sim2, resulting from trisomy 21, may play a 
role in learning impairments associated with the DS population. 
Singleminded-2 and Cancer 
 In addition to its potential role in the etiology of DS, Sim2 has been studied as a 
putative oncogene in several tissue types.  Sim2s expression has been reported in tumor-
derived cell lines, and tissue samples from carcinomas of the colon, prostate, and 
pancreas, but not in breast, lung, or ovarian cancers (DeYoung et al. 2003b).  Using 
antisense oligonucleotides, this group has reduced Sim2s expression in cell lines derived 
from both colon and pancreatic carcinomas (DeYoung et al. 2003b; DeYoung et al. 
2003a; Aleman et al. 2005).  In cells with low levels of Sim2s, they reported reduced 
proliferation, increased caspase-dependent apoptosis, and slower growth in nude mouse 
xenograft models when compared to control cells.  Surprisingly, in the discussion of 
their work, the authors describe the possible association of Sim2s with Down Syndrome, 
but Hasle and colleagues did not find an increase in colon tumors associated with such 
individuals (Hasle et al. 2000).  There is no mention, thus far, of pancreatic or prostate 
tumor occurrence in the DS population by any group, although several investigators 
report a decrease in all solid tumors associated with trisomy 21 (Hasle et al. 2000; Hasle 
2001; Dixon et al. 2006; Sullivan et al. 2007).   
 Our lab has found a very different relationship between Sim2s and cancer.  Most 
of the work published on Sim2 as a tumor suppressor has been done in breast cancer 
cells, and it is worth noting that De Young et. al. did not detect any expression of Sim2s 
in mammary carcinomas (DeYoung et al. 2003b).  The expression of Sim2s has been 
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shown to be high in normal mammary epithelial cells, and to decrease with 
transformation to cancer cells (Kwak et al. 2007).  When Sim2s is re-introduced to MD-
MBA-435 cancer cells, proliferation, invasion, and anchorage-independent growth are 
all reduced.  Additionally, in this cell type SIM2s reduced mRNA levels and activity of 
MMP3, known to be involved in cancer metastasis (Kwak et al. 2007).  Sim2s is the 
primary isoform expressed in relatively non-aggressive MCF-7 breast cancer cells, albeit 
at a low level.  Elimination of SIM2s, using shRNA, led to an increase in proliferation, 
invasion, and growth of cells in nude mouse xenografts (Laffin et al. 2008).  In this 
model, SIM2s was found to inhibit expression of Slug and MMP2, both known 
contributors to cancer invasion and metastasis, and reduction of SIM2s led to a loss of 
epithelial characteristics, such as E-Cadherin and Keratin-18 expression, and acquisition 
of the mesenchymal markers, N-Cadherin and Vimentin.   
 Recently, it was shown that stem cells and cells undergoing EMT were very 
similar (Morel et al. 2008).  By using cell sorting and other techniques, the authors were 
able to conclude that the EMT process requires a de-differentiation of epithelial cell 
types to a progenitor-like cell population under normal developmental circumstances.  
Our data suggest that SIM2s is necessary for the maintenance of the differentiated 
epithelial phenotype, characterized by expression of epithelial-specific keratins and cell 
contact proteins; therefore, our hypothesis is that Sim2s promotes differentiation of 
epithelial cells in the mammary gland, possibly playing a role in the formation and 
function of alveolar epithelial cells during lactation.                               
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CHAPTER II 
MATERIALS AND METHODS 
 
 
Cell Culture 
 
 HC11 cells were maintained in growth media consisting of RPMI 1640 (GIBCO 
22400-089), 10% calf serum (Atlanta Biologicals S11450), 5 µg/mL insulin (Sigma 
I6634), 50 µg/mL gentamicin (GIBCO 15710-064), and 50 ng/mL rhEGF (QED 
Biosciences Inc., 36001P).  Cells were passaged approximately every other day, based 
on confluence.  For differentiation, cells were allowed to remain confluent for 3 days, 
with fresh growth media added daily.  Then, cells were washed 2 times with PBS, 
followed by addition of priming media (PM).  Basal PM included RPMI 1640 (GIBCO), 
10% charcoal-stripped donor horse serum (Atlanta Biologicals S12150), 50 µg/mL 
gentamicin (GIBCO), and 5 µg/mL insulin (Sigma).  Hydrocortisone (HC Sigma H0888) 
was added to a final concentration of 1 µg/mL for 24 h.  Then both HC and ovine 
Prolactin (Prl NIDDK oPRL 21) were added at 1 µg/mL for the duration of the 
differentiation protocol (ranging from 4 h to 4 days), adding fresh PM + HC and Prl 
every 24 h.  Differentiation was assessed by formation of cytoplasmic lipid droplets in 
the majority of the cells, and also by expression of Csn2. 
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Chromatin Immunoprecipitation Assay (ChIP) 
Chromatin Harvest 
 Formaldehyde (Sigma F1635) was added to fresh culture media (final 
concentration 1%) and cells were incubated at room temperature (RT) for 10 min with 
gentle rocking.  Glycine (Sigma G8898) was added to a final concentration of 125 mM 
and allowed to quench formaldeyhde for 5 additional min at RT.  Cells were washed 2 
times with ice-cold PBS and scraped in cold PBS containing 25x Complete protease 
inhibitors (CPI Roche 11-697-498-001).  Cells were pelleted by spinning at 2000 rpm 
(805 x g) for 4 min using an Eppendorf 5810R centrifuge chilled to 4 C.  SDS lysis 
buffer (50mM Tris pH 8.1, 10 mM EDTA, 1% SDS, 25x CPI) was added, and 
resuspended cells were incubated on ice for 10 min.  Using a sonicator (Heat Systems 
Ultrasonics Inc., Model W-380), DNA was sheared in 10 second pulses, 10 times, 
allowing the lysate to cool on wet ice for 1 min after every 2 pulses.  Debris was pelleted 
by spinning at 13,200 rpm (16.1K x g) in an Eppendorf 5415D centrifuge for 10 min at 4 
C.  Chromatin was stored at -80 C in 100 µL aliquots. 
    
Standard ChIP Assay     
 One aliquot of chromatin was used for each assay.  ChIP dilution buffer (0.01% 
SDS, 1.1 % Triton X-100, 1.2 mM EDTA, 16.7 mM Tris pH 8.1, 167 mM NaCl, 25x 
CPI) was added to 5-fold dilution.  Normal rabbit serum (5 µL Santa Cruz sc2338) and 
60 µL salmon sperm DNA/Protein A or Protein G Agarose (Upstate Protein A 16-157; 
Protein G 16-201) was added for 30 min and chromatin was precleared at 4 C with 
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agitation.  Beads were pelleted by spinning in an Eppendorf centrifuge at 200 x g for 1 
min.  Lysate was precleared once more with 60 µL of agarose beads (no serum).  
Antibodies were added and chromatin was agitated at 4 C overnight (see Table 2 for 
antibody sources and conditions).  The following day, 60 µL of agarose beads were 
added for 1 h at 4 C with rocking.  Beads were pelleted and washed consecutively for 10 
min in each solution: low salt wash (0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 20 
mM Tris pH 8.1, and 150 mM NaCl), high salt wash (0.1 % SDS, 1 % Triton X-100, 2 
mM EDTA, 20 mM Tris pH 8.1, and 500 mM NaCl), lithium chloride wash (0.25 M 
LiCl, 1 % NP-40, 1 % sodium deoxycholate, 1 mM EDTA, and 10 mM Tris pH 8.0), and 
twice in TE buffer (10 mM Tris pH 8.0 and 1 mM EDTA).  TE washes took place at RT 
and others at 4 C.  Immune complexes were eluted from beads in 1 % SDS and 0.1 M 
NaHCO3, adding 250 µL to each aliquot and rocking for 15 min at RT, then repeating 
for a total of 500 µL eluate.  NaCl was added for a final concentration of 0.3 M with 1 
µL of 10 mg/mL RNAse-A.  Eluate was incubated at 65 C for 5 h to reverse 
formaldehyde crosslinks.  Two and one half volumes of 100 % EtOH were added to each 
sample and they were placed at -20 C overnight.  On the third day, chromatin was 
pelleted by spinning in an Eppendorf centrifuge at 16.1K x g for 10 min.  Supernatant 
was removed and the pellet resuspended in 100 µL H2O, with 2 µL 0.5 M EDTA, 4 µL 1 
M Tris pH 6.5, and 1 µL of 20 mg/mL proteinase K (Sigma 93161722).  Samples were 
incubated at 45 C for 2 h, and then purified using a Qiagen PCR purification kit (Qiagen 
28106).  DNA was eluted in 50 µL elution buffer (supplied with kit).  PCR was 
performed according to conditions listed in Table 1. 
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 Table 1.  Primer Sequences Used in RT-PCR and Q-PCR Reactions. 
Sense CAC-TTG-GCT-GGA-GGA-ACA-TGT-AGT-T
Antisense ACA-TCT-GAA-GTT-CTT-ACC-TTT-AGT-GG
Sense CAT-ATG-CTC-AGG-CTC-AAA-CCA-TCT-CT
Antisense GTA-CTG-CAG-AAG-GTC-TTG-GAC-AGA-C
Sense TAC-AGC-TTC-ACC-ACC-ACA-GC
Antisense AAG-GAA-GGC-TGG-AAA-AGA-GC
Sense AAG-AAC-CAA-CCC-ATA-TCC-CC
Antisense GGC-ATA-ATG-CGG-CAC-ATC-ATA-AGG
Sense CTA-ACA-TCA-AAT-GGG-GTG-AGG
Antisense TCA-TAC-TTG-GCA-GGT-TTC-TCC
Sense CAT-CGT-CTT-GCA-GAT-CGA-CAA
Antisense GAC-TGG-CGC-ATG-GCT-AGT-TC
Sense TCC-CTG-GTG-TTG-GGC-TTC-T
Antisense ACA-GCG-TGT-GCA-CTT-CAT-G
Sense TCA-GTC-CAT-GTT-CCC-AAA-AGC
Antisense CTC-GTT-GGT-TTG-GCA-GAT-GA
Sense CGC-CCC-CAC-GCA-GTT
Antisense GCC-AGA-GCA-CGA-TGG-ATC-TG
Sense GAA-TGG-GCC-TGT-GTT-TTA-TTT-CA
Antisense TGT-GCT-GCC-GTT-GTC-GTT
Sense TCA-CGT-CTT-CAG-CAG-CAA-GAA
Antisense AGA-AGC-GTG-CCA-CCT-CAC-A
Sense AAC-CAG-CTC-CCG-TGT-TTG-AC
Antisense ACT-CTG-AGG-AAC-GGC-GAA-AA
54
GAPDH 54
59
60
57
mCsn2 Proximal Promoter
mCsn2 Exon VII
mActin Exon
Keratin-18
HA Sequence
Q-PCR
Claudin-7 Q-PCR
Wap Q-PCR
WDNM1 Q-PCR
Lalba Q-PCR
Target Strand Sequence Anneal C
pan Sim2 Q-PCR
Sim2s Q-PCR
 
 
Re-ChIP Assay 
 The standard ChIP protocol was followed until beads were washed with TE.  
Following TE washes, beads were incubated with 1 volume of 20 mM DTT at 37 C for 
30 min with agitation.  Beads were pelleted by centrifugation at 16.1K x g and 
supernatant was diluted 15-fold in re-ChIP dilution buffer (1% Triton X-100, 2 mM 
EDTA, 150 mM NaCl, and 20 mM Tris pH 8.1) and 25x CPI.  Ten percent was reserved 
for input samples, and the remainder was divided in half, for primary antibody 
incubation and IgG control.  After addition of antibodies, samples were processed 
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according to standard ChIP protocol, except for the final step, in which DNA was eluted 
after clean-up in 30 µL elution buffer instead of 50 µL.   
 
Western Blot Assay 
Protein Isolation 
 Cells were washed once with PBS and scraped in PBS containing 25x CPI 
(Roche).  Cells were pelleted by spinning in a pre-cooled Eppendorf centrifuge at 2000 
rpm for 4 min.  Lysis buffer [20 mM Tris-Cl pH 8.0, 137 mM NaCl, 10 % glycerol, 1 % 
NP-40, 2 mM EDTA + 25x CPI + phosphatase inhibitors (0.5 mM NaMolybdate, 0.1 
mM Na Orthovanadate, and 1 mM NaF)] was added and resuspended cells were agitated 
at 4 C for 30 min.  Debris was pelleted by spinning in a cooled Eppendorf centrifuge at 
16.1K X g for 10 min.  Aliquots of 200 µL were stored at -20 C.  If used immediately, 
they were stored at 4 C.  Protein content was estimated using the RCDC Protein Assay 
(BioRad 500-0120). 
 
Standard Analysis 
 Protein samples were diluted in 30 µL of H2O per sample.  Six µL of 6x SDS 
loading buffer (60 % glycerol, 0.3 M Tris pH 6.8, 12 mM EDTA, 12 % SDS, 6 % beta-
mercaptoethanol, 0.5 % bromophenol blue) were added and samples were boiled for 5 
min, followed by 5 min of cooling on ice.  Acrylamide gels ranging from 8%-12% were 
used for analysis.  Depending on the size of the target protein, gels were run at 110mV 
(constant V) for 1-2 h and transferred to PVDF membranes for 1.5 to 3 h at 110mA 
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(constant mA).  After a 5 min wash in PBS + 0.05 % Tween 20 (PBST), membranes 
were blocked for 1 h or overnight in PBST + 5 % milk (BioRad 170-6404).  See Table 2 
for antibody sources and incubation conditions.  Proteins were visualized using the 
Amersham ECL Plus western blotting detection reagent (GE Healthcare RPN 2132) on 
Amersham Hyperfilm (GE Healthcare RPN1678K).  All films were scanned using a Dell 
All-in-one scanner. 
 
 
      Table 2.  Antibodies Used for ChIP Analyses. 
     
RNAPII Abcam ab-26721 5
S5RNAPII Abcam ab-24759 5
Stat5a Chemicon AB3163 8
AcH3 Upstate 06-599 5
Cdk9 Santa Cruz sc7331 5
Sim2 Chemicon AB4145 5
Antigen Source Catalog # ChIP (µg)
 
 
 
PCR Analysis 
RNA Isolation from Cells 
 Cells were washed with PBS and RNA was isolated using the RNEasy Mini Kit 
(Qiagen 74106) following the protocol for spin isolation.  Qia-Shredder columns were 
used to homogenize cells prior to RNA isolation (Qiagen 79656).  RNA was eluted in 30 
to 50 µL RNAse-free H2O and stored at -80 C.  To remove contaminating genomic 
DNA, 8 µL aliquots of RNA were treated with 10 U of DNAse (Roche 10776785001) 
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and 1 µL 10x DNAse buffer (200mM Tris pH 8.4, 20mM MgCl2, 500mM KCl) for 15 
min at room temperature.  One µL of stop solution (50 mM EDTA) was added to inhibit 
the DNAse reaction.  RNA concentration was determined using a BioRad Spec (BioRad 
Smartspec Plus). 
 
RNA Isolation from Tissue 
 To isolate total RNA from tissue, sections of approximately 0.5 cm by 0.5 cm 
were homogenized in Trizol reagent (Invitrogen) for 30 seconds.  Samples were then 
centrifuged for 5 min at 16.1K x g to pellet debris.  Supernatant was mixed with 200 µL 
of chloroform and allowed to incubate at RT for 5 min.  Following centrifugation at 12K 
x g for 15 min, aqueous layer was mixed with 1 mL of 75 % EtOH and inverted several 
times.  Samples were centrifuged for 10 min at 12K x g.  Supernatant was aspirated and 
pellets were washed in 75 % EtOH, then centrifuged for 5 min at 7.5K x g.  Supernatant 
was aspirated again, and pellets were resuspended in 100 µL of RNAse-free H2O.  
Rehydrated RNA was subjected to purification according to that described in the 
previous section for RNA isolation from mammalian cells.  
 
Reverse Transcription  
 Depending on the RNA concentration, 1-2 µg of RNA was used for reverse 
transcription reactions.  One µL of each 10 mM dNTPs (Invitrogen) and Oligo dT 
(Invitrogen 18418-012) or random primers (Invitrogen 48190-011) was added to RNA in 
H2O for a total volume of 12 µL.  The sample was incubated at 70 C for 10 min, then 4 
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µL 5X first strand buffer, 2 uL 0.1 M DTT, 1 µL RNAse Out (Invitrogen 10777-019), 
and 1 µL Superscript III reverse transcriptase (Invitrogen 18080-044) were added for a 
new total volume of 20 µL per sample.  The sample was incubated at 42 C for 50 min, 
followed by 70 C for 15 min.  cDNA was diluted to 20 to 25 ng/µL with H2O and stored 
at -20 C. 
 
Q-PCR (Real Time) 
 Two µL of each cDNA sample were mixed with 12.5 µL 2x SyberGreen master 
mix (Applied Biosystems 4309155), 8 µL H2O, and 2.5 µL of both sense and antisense 
primers and added to a 96 well plate (Applied Biosystems MicroAmp N801-0560).  
Reactions were run according to the following cycle conditions:  95 C for 10 min, and 40 
cycles of 95 C for 10 seconds followed by 60 C for 1 min.  Analysis was performed 
using the ddCT method.  For mouse mammary tissue samples, expression of Claudin 7 
was used to normalize mRNA levels of assayed genes (Blackman et al. 2005).  
 
 RT-PCR   
 The following master mix was used for RT-PCR analysis:  10x PCR buffer, 0.4 
µM dNTPs, 2 mM MgCl2, 1 µM each sense and antisense primers, 1.25 units of Taq 
polymerase (Invitrogen 18038-042), and 2 µL cDNA sample in a total volume of 25 µL 
per reaction.  For all PCR reactions, the initial denaturation step was performed at 94 C 
for 5 min and the final elongation at 72 C for 5 min.  The first denaturation round of 
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each cycle was performed at 94 C for 30 seconds in all reactions.  Other varying 
conditions for each primer set are listed in Table 1. 
 
Immunostaining 
IHC     
 Tissue was harvested and immediately placed in chilled 4% paraformaldehyde 
for 12-24 hours, depending on the thickness of the tissue.  The Veterinary Integrative 
Biosciences Histology Core Facility paraffin-embedded and sectioned all tissue, and also 
provided all H&E stained sections.  For immunohistochemical or immunofluorescent 
analysis, slides were heated in a 60 C oven for 30 min to melt the paraffin, followed by 
deparaffinization in graded alcohols according to the following protocol:  2 washes in 
Xylenes for 5 min each, 2 washes in 100 % EtOH for 3 min each, 1 wash for 3 min in 
each 95 % EtOH, 70 % EtOH, and PBS.  Antigen retrieval conditions varied depending 
on the antibody and target tissue and can be found in Table 3.  All antigen retrieval was 
performed in 10 mM sodium citrate buffer in the microwave.  For IHC, endogenous 
peroxidases were blocked by incubating the slides in 3 % H2O2 for 6 min.  The 
Avidin/Biotin blocking kit was used for all IHC stained slides (Vector Labs SP-2001).  
Sections were blocked in PBST containing 10 % normal horse serum (NHS), and 
incubated in primary antibody diluted in PBST + 1 % NHS, or IgG (Mouse IgG Upstate 
12-371; Rabbit IgG Santa Cruz sc2027) overnight at 4 C.  After incubation in secondary 
antibody, diluted 1:250 in PBST + 1 % NHS, the ABC Kit (Vector Labs PK-6200) was 
used for signal amplification and the DAB Kit (Vector Labs SK-4100) was used to 
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visualize proteins.  Slides were counterstained with methyl green [0.5 g methyl green in 
100 mL 0.1 M sodium acetate buffer (1.36 g sodium acetate trihydrate, 100 mL H20, pH 
4.2 with glacial acetic acid)] and mounted using Permount (Fisher).  The M.O.M. Kit 
(Vector Labs BMK-2202) was used for mouse primary antibodies.        
 
 
 Table 3.  Antibodies Used for Immnohistochemical Analyses. 
        
Npt2b Alpha Diagnostics NPT2B11-A 1.400 1' high 9' med
Aqp5 Alpha Diagnostics AQP51A 1.250 None
β-Casein Santa Cruz FL-231 1.100 None
PR Neomarkers RB9017 1.600 1' high 9' med
Cleaved Caspase-3 Cell Signaling 9611S 1.200 1' high 9' med
Ki67 Neomarkers RM-9106 1.500 1' high 9' med
HA Sigma H6908 1.250 1' high 9' med
Sim2 Millipore AB4145 1.250 15 min high
Ag RetrievalTarget Source Catalog # Dilution
 
 
 
Animal Handling/Genotyping 
 All mice were housed in the Comparative Medicine Program main facility with 
ad libitum access to water and a standard rodent diet containing 4 % fat.  To genotype 
mice, the tip of the tail was treated with lidocaine gel for approximately 2 min, then less 
than 0.5 cm was cut for analysis.  Styptic powder was used to control bleeding.  All tail 
tissue to be used for genotyping harvested from live mice was done so between 2 and 4 
weeks of age.  Tails were kept at 4 C until digestion.  To isolate genomic DNA, the 
Promega Wizard Kit was used following manufacturers protocol for mouse tail tissue.  
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Rehydrated DNA was quantitated using a BioRad Spectrophotometer and diluted to a 
final concentration of 25 ng/µL.  Two µL of diluted DNA were used for PCR.  To 
genotype MMTV-mSim2sHA mice, the following primers were used:  MMTV Sense 
and mSim2 Seq2 Antisense, expected product size 850 bp.  To genotype MMTV-Neu 
mice, the following primers were used:  rNeu Sense and rNeu Antisense, expected 
product size 600 bp.  Alternatively, the RED-Xtract-N-Amp Kit (Sigma XNAT) was 
used beginning in June 2008 for genomic DNA isolation and PCR analysis.  All steps 
performed were according to the manufacturers instructions for extraction and PCR 
conditions, except that less than 0.5 cm of tail tissue was used rather than the 
recommended 1.0 cm.   
 
Retroviral Transduction 
 Retroviral plasmids were transfected into 293T Viral Packaging Cells, which 
stably express Amphotrophic envelope proteins and are referred to as 293-Ampho.  Up 
to 10µg of plasmid was transfected using Gene Juice (Novagen 70967), in a 3:1 ratio of 
Gene Juice (µL) to DNA (µg).  Media was changed 24 h later, and collected for infection 
48 h and 72 h later.  Viral media was filtered through 0.45 µM syringe filters and 
polybrene was added to a final concentration of 4 µg/mL.  Viral media was added to 
target cells, followed by centrifugation at 1200 rpm for 1 h.  Target cells were incubated 
at 32 C for the duration of the infection protocol to promote viral stability.  Selection 
was carried out using puromycin at varying concentrations, depending on the target cell 
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type.  Selection was considered complete when all cells in a mock-infected plate were 
dead.  
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CHAPTER III 
THE ROLE OF SIM2S IN MAMMARY GLAND DEVELOPMENT 
 
Sim2s Expression is Regulated by Developmental Stage  
 Previously, we have shown that Sim2 is highly expressed in normal mammary 
epithelial cells, and that expression is lost in aggressive breast cancer cells (Kwak et al. 
2007).  In addition, we have determined that SIM2s is the predominant isoform 
expressed in the human MCF7 breast cancer cell line (Laffin et al. 2008).  To evaluate 
the expression pattern of Sim2s in the mouse mammary gland, RNA was isolated from 
whole mammary gland lysates harvested during virgin development, pregnancy, 
lactation, and involution.  Q-PCR analysis was used to determine the relative amounts of 
Sim2s expressed in the mammary glands during each developmental stage (Fig. 6A).  
Sim2s expression is detectable in mammary glands from nulliparous, or virgin, females, 
and it declines during pregnancy, when the epithelial cells are rapidly proliferating.  It 
then begins to increase in late pregnancy and reaches a peak during the first week of 
lactation, when the gland is terminally differentiated and secreting large amounts of 
milk.  Sim2s expression declines again during involution, when most of the milk-
producing alveolar epithelial cells are dying and the gland is remodeling.  In situ 
hybridization was used to evaluate Sim2 mRNA localization in the mammary glands of 
both nulliparous and lactating mice (Fig. 6B).  High levels of Sim2 mRNA were found to 
be localized in the epithelial cells of the lactating gland, as compared to those of a 
nulliparous female. 
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 The mammary gland experiences a gain of function phase during the first week 
of lactation, and the synthetic activity of alveolar epithelial cells is maximal at 
approximately day 10 of lactation.  To more closely evaluate the expression of Sim2s 
during the first week of lactation, RNA was isolated from whole mammary glands 
harvested 1, 4 or 7 days after parturition (L1, L4, and L7, respectively), and subject to Q-
PCR analysis.  In addition, expression of four major milk protein genes was evaluated, 
including Csn2, Wap, Lalba, and Expi, which is known as WDNM1.  Csn2 encodes the 
β-Casein protein, Wap and Expi encode secreted protease inhibitors, and Lalba encodes 
α-Lactalbumin, a subunit of the lactose synthetase enzyme.  Sim2, Csn2, and Wap 
showed a progressive increase in expression from day 1 through day 7 of lactation (Fig. 
7A-C).  Interestingly, expression of Lalba and Expi was highest on day 1 of lactation, 
and did not increase further during the first week of lactation, suggesting that expression 
of these genes is regulated by a different mechanism than Csn2 and Wap (Fig. 7D-E).   
 
Generation of the MMTV-Sim2sHA Mouse 
 In Drosophila, dsim is required for proper formation of the central midline of the 
developing CNS, and to establish midline cell fate (Chang et al. 2001).  Expression of 
dsim in lateral neural cells causes them to adopt a midline fate, characterized by 
expression of midline-specific genes (Menne et al. 1997).  Based on the role of dsim in 
cell fate determination and the high expression of Sim2s in differentiated mammary 
epithelium, we hypothesized that Sim2s plays a role in maintaining lactogenic 
differentiation and function of the alveolar epithelial cells.  To test our hypothesis, we  
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created a transgenic mouse model, which expresses HA-tagged Sim2s under control of 
the mouse mammary tumor virus long terminal repeat (MMTV LTR) promoter (Fig. 
8A), which confers expression to the mammary epithelium.  It has been reported that 
MMTV can drive expression in several tissues in addition to the mammary epithelium 
(Robinson et al. 2001).  RNA, isolated from various organs of three adult transgenic 
females, was pooled and evaluated for transgene expression.  Using primers that 
specifically recognize the transgene, we determined that the MMTV LTR drives 
expression of the Sim2s transgene exclusively in the mammary gland (Fig. 8B).  
Immunohistochemistry was used to detect the HA tag in mammary glands from eight-
week virgin (V8) WT or transgenic females.  Using IHC, we observed HA positive cells 
in the mammary epithelium of transgenic females, but not in non-transgenic littermates 
(Fig. 8C).  In addition, HA positive staining in transgenic glands showed a chimeric 
pattern, which is consistent with other reported MMTV-driven transgenes (Robinson et 
al. 2001).   
 Mice have three pairs of thoracic mammary glands, and two pairs of inguinal 
glands for a total of 10 mammary glands.  Due to the accessibility, the number 4, or first 
inguinal, glands are routinely utilized for mammary gland biology studies.  Mammary 
tissues were harvested from female mice at various developmental timepoints including 
nulliparous, pregnant, lactating, and involuting glands.  Mammary glands were harvested 
during the estrus phase, due to the possibility of ovarian hormone influence on 
expression of some mammary specific genes (Robinson et al. 1995).  Unless otherwise 
indicated, all females were nulliparous or primiparous.  For involution samples, females  
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were allowed to nurse pups for 10 days, and the glands were harvested at given time 
intervals after forced weaning.   
 During virgin development, no gross morphological defects were observed in 
TEBs or mature ductal structures in transgenic females as compared to WT controls 
(Fig. 9A-B).  In addition, no abnormalities were detected at pregnancy day 6 or 16 (P6 
and P16, respectively; Fig. 9C-D).  Two weeks after pup removal, transgenic glands 
were indistinguishable from WT glands (Fig. 9E).   
 Mammary glands were harvested from both WT and transgenic females at L1, 
L4, and L10.  Evaluation of epithelial structures in H&E stained sections did not reveal 
any morphological differences between the two groups at any stage (Fig. 10A-C).  At 
L1, the alveoli occupied a substantial portion of the mammary gland, and the relative 
amount of epithelium increased by L4.  At L10, visibly distended alveoli could be 
observed.  Upon closer examination (inset) it was revealed that the cells within the 
alveoli were metabolically active and many contained CLDs.  Overall, examination of 
the mammary glands of transgenic mice at various stages of development did not reveal 
any gross morphological differences, when compared to glands from WT mice.   
 
Accelerated Lactogenic Differentiation in Transgenic Females 
 It has been reported that early expression of genes associated with cell fate 
determination can promote the formation of differentiated alveolar epithelial cells in 
nulliparous females (Jiang and Zacksenhaus 2002; Kouros-Mehr et al. 2006; Oakes et al. 
2008).  These reports, taken together with the pattern of Sim2s expression in WT  
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mammary glands, led us to hypothesize that precocious expression of Sim2s in the 
mammary epithelium would promote lactogenic differentiation.  To determine if 
precocious Sim2s expression leads to upregulation of milk protein genes, Q-PCR 
analysis was used on RNA isolated from whole mammary glands of V8 females.  When 
compared to WT glands, mRNA levels of Csn2 and Wap in transgenic glands were 
significantly elevated (Fig. 11A-B).  Surprisingly, differences were not detected in the 
expression of Lalba or Expi in transgenic glands compared to WT (Fig. 11C-D).  The 
differential regulation of Csn2 and Wap by Sim2s was reminiscent of the patterns of 
gene expression observed during the first week of lactation in WT glands (Fig. 7). 
Together, these data suggest that Sim2s plays a role in regulating the transcription of a 
subset of milk protein genes in the mammary epithelium.   
 Various cell surface proteins have been determined to be developmentally 
regulated in the mammary gland.  Aquaporin-5 (Aqp5) is localized to the luminal 
surface of ductal epithelial cells, and its expression is lost during lactation.  Solute 
carrier 34a2 (Slc34a2), which encodes the sodium-inorganic phosphate cotransport 
protein referred to as Npt2b, is upregulated during lactation and is localized to the 
luminal surface of the epithelium.  Immunohistochemistry was used to evaluate Aqp5 
and Npt2b in mature mammary glands from nulliparous WT or transgenic females. 
Differences in Aqp5 were not detected between the groups at this developmental stage 
(Fig. 12A).  In approximately 70% of transgenic glands examined, Npt2b was found on 
the luminal surface of the ductal epithelial cells (Fig. 12B).  In addition, we were also 
able to detect β-Casein in the cells of mature nulliparous transgenic mice (Fig. 12C).   
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We have previously shown a relationship between Sim2 expression and cell proliferation 
(Kwak et al. 2007).  To determine if proliferation is reduced in transgenic glands, IHC 
was used to detect Ki67 expression.  No differences were seen between WT and 
transgenic glands with regards to proliferation, which was not surprising given the 
normal ductal morphology (Fig. 12D). 
 PR has been shown to be required for proper alveolar expansion during 
pregnancy.  Further, the pattern of mammary PR expression has been proposed to reflect 
global gland maturity (Seagroves et al. 2000).  In immature virgins, PR is found in 
nearly all ductal epithelial cells.  This has been hypothesized to prevent premature side 
branching and alveolar formation prior to completion of branching morphogenesis.  
Once the female reaches maturity, PR expression adopts a more chimeric pattern, and it 
is not found in every cell.  During pregnancy, overall amounts of PR decrease in the 
gland, and PR is undetectable during lactation (Aupperlee et al. 2005).  We have shown 
that Sim2s can promote lactogenic differentiation, characterized by increased expression 
of milk protein genes, and upregulation of Npt2b in luminal epithelial cells.  
Immunohistochemical analysis was used to determine if Sim2s altered the expression of 
PR in mammary glands from WT and transgenic females.  Differences in PR expression 
were not detected in glands from mature nulliparous females (Fig. 13A & D).  At P6, 
mammary glands of transgenic mice expressed significantly less PR than glands from 
WT mice at the same timepoint, consistent with accelerated lactogenic differentiation 
(Fig. 13B & E).  Although this observation was not true for every sample, the reduction  
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in PR expression associated with transgenic females was significant in the majority 
(70%) of P6 glands.  Significant differences in PR expression were not detected at P16 
(Fig. 13C & F).  
  
Mammary Differentiation during Pregnancy and Lactation 
 Milk protein genes are expressed asynchronously during pregnancy (Robinson et 
al. 1995).  Expi and Csn2 are detectable in early pregnancy, but show high variability in  
the amount and localization of expression.  Wap is expressed at low levels several days 
after Expi and Csn2; however, it is restricted to cells that express Csn2, and the two 
show the same pattern of mRNA localization (Robinson et al. 1995).  Expression of 
Lalba is not detectable until very late in pregnancy.  In mammary glands of transgenic 
females, we have shown an acceleration of lactogenic differentiation during virgin 
development compared to WT littermates.  To determine if transgenic females 
experience enhanced alveolar cell differentiation during pregnancy, RNA was isolated 
from whole mammary glands and used in Q-PCR analysis for Expi, Lalba, Csn2 and 
Wap. At P6, mRNA levels of all four of the genes analyzed were significantly higher in 
glands of transgenic females compared to WT (Fig. 14A-D).  By P16, however, there 
were no detectable differences between the two groups (Fig. 14A-D).  These data 
suggest that the epithelial cells experience accelerated differentiation during early 
pregnancy in transgenic females.   
 Upon parturition, milk protein gene expression is dramatically enhanced, but 
does not yet show uniform expression throughout the alveolar and ductal epithelium  
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(Robinson et al. 1995).  To determine if MMTV-Sim2s females express higher levels of 
milk protein genes during the first week of lactation, Q-PCR was used to analyze Expi, 
Lalba, Csn2 and Wap.  Differenced were not detected in the expression of Expi or Lalba 
at L2 or L4 between WT and transgenic glands (Fig. 15A & B).  Both Wap and Csn2 
were upregulated from L2 to L4 in WT glands, but only Csn2 expression was 
significantly enhanced in transgenic glands at L4 (Fig. 15C & D).  It is possible that the 
levels of expression of Wap, Expi, and Lalba were too high to detect significant 
differences between WT and transgenic glands. 
 Delayed involution following pup removal has been reported in transgenic mice 
expressing genes associated with precocious lactogenic differentiation, such as Stat5a, 
MTA-1, and a constitutively active form of pRb (Iavnilovitch et al. 2002; Jiang and 
Zacksenhaus 2002; Bagheri-Yarmand et al. 2004).  To characterize mammary glands of 
transgenic mice following involution, females were allowed to nurse pups for 10 days, 
and then weaned.  Mammary glands were harvested 24, 48, or 72 hours after pup 
removal and stained using H&E (Fig. 16A-C).  Examination of H&E stained sections 
from females harvested at the indicated timepoints revealed a noticeable delay in 
postlactational epithelial regression by 48 hours after pup removal, and a more dramatic 
delay 72 hours after weaning (Fig. 16B-C).  IHC analysis was performed on sections to 
detect the active Caspase-3 protein, which is involved in apoptosis of alveolar epithelial 
cells (Fig. 16D-F).  There appeared to be more cleaved Caspase 3-positive cells in the 
mammary glands of WT females at all three timepoints as compared to glands from  
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transgenic females, indicating a reduction in apoptosis that is consistent with a delayed 
epithelial regression following pup removal.   
 IHC was also used to detect Sim2 in mammary glands harvested from WT 
females 72 hours after forced weaning.  Using this technique, we found Sim2 localized 
to the epithelial cells lining the alveoar lumens, but did not detect Sim2 in the cells that 
had been extruded from the epithelial layer (Fig. 17A arrows).  Nuclear staining was not 
observed using IgG as a negative control (Fig. 17B).  Together, these data suggest that 
Sim2 promotes cell survival following lactation, and loss of Sim2 expression is a 
prerequisite for apoptosis of alveolar epithelial cells.         
 In mice, we have shown that Sim2s is developmentally regulated and is highly 
expressed in terminally differentiated mammary epithelium.  In addition, precocious 
expression of Sim2s, driven by the MMTV LTR, leads to upregulation of Csn2 and Wap 
in mammary glands from mature nulliparous females.  This is accompanied by moderate 
production and appropriate localization of Npt2b.  Reduced levels of PR in early 
pregnancy, associated with enhanced expression of four major milk protein genes 
suggests that mammary epithelial cells from transgenic females experience accelerated 
lactogenic differentiation.  By late pregnancy, no differences in gene expression were 
detected between WT and transgenic glands.  During the first week of lactation, Csn2 
was significantly upregulated in glands from transgenic females compared to those from 
WT controls.  In addition to early lactogenic differentiation seen during mammary 
development in transgenic females, a delay in involution, characterized by reduced 
levels of active Caspase 3, was observed.  Cells that had been extruded from alveolar  
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walls in WT females were found to be negative for Sim2 expression, as determined by 
IHC analysis.  The HC11 cell line, described in Chapter I and discussed in detail in the 
next chapter, is an excellent model to use for elucidation of the factors that regulate 
transcription of the Csn2 gene.  
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     CHAPTER IV 
 
SIM2S AND LACTOGENIC DIFFERENTIATION IN VITRO 
 
Sim2s Expression in HC11 Cells 
 HC11 cells are derived from the COMMA-D line, isolated from a mid-pregnant 
BALB/c mouse (Ball et al. 1988).  After they reach confluence, treatment with 
hydrocortisone (HC) and prolactin (Prl) results in a robust induction of Csn2.  This cell 
line provides an excellent model to study the transcriptional regulation of one major milk 
protein gene in response to hormonal stimulation.  We have shown, in vivo, that Sim2s 
expression increases during the first week of lactation, when circulating Prl levels are 
high.  To determine if Sim2s is regulated in a similar manner in vitro, Q-PCR analysis 
was used to evaluate expression pattern of Sim2s in proliferating, undifferentiated (UN) 
HC11 cells, and in cells treated with hydrocortisone and Prl for 1 or 4 days (Prl1 and 
Prl4, respectively).  Sim2 expression was induced after 1 day of Prl treatment, and the 
expression increased further 4 days after Prl treatment (Fig. 18A).  Western blot 
analysis, performed on undifferentiated HC11 cells or cells treated for 4 days with Prl, 
revealed that Sim2s was the predominant isoform expressed in this cell type (Fig. 18B).  
Detection of beta-Casein by western blot analysis confirmed that the cells responded 
appropriately to hormonal stimulation, and beta-Actin was used as a control for protein 
loading (Fig. 18B).   
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Csn2 Expression Is Directly Related to Sim2s Expression 
 To recapitulate the model described in the previous chapter, retroviral 
transduction was used to express Sim2s (Sim2s), or empty vector (Control) in HC11 
cells.  RNA was isolated from undifferentiated (UN) Control and Sim2s HC11 cells, or 
from cells treated for 4, 8, and 24 hours with HC and Prl (Prl).  Q-PCR analyis revealed 
a significant increase in expression of Csn2 in Sim2s cells 4 hours after hormonal 
stimulation, and the enhanced expression was maintained throughout the timecourse 
(Fig. 19A).  In Control cells, the pattern of Csn2 induction in response to hormonal 
stimulation was similar to that seen in Sim2s cells (Fig. 19A inset).  Sim2s 
overexpression, however, was not sufficient to induce Csn2 in the absence of Prl (UN).  
A higher amount of β-Casein protein was also detected in Sim2s cells compared to 
Control cells following Prl treatment, using Western blot analysis (Fig. 19B).  
 To determine if Sim2s is necessary for Csn2 expression in differentiated HC11 
cells, shRNA was used to reduce protein levels.  Two constructs, targeting either Exon 6 
or Exon 10 of mouse Sim2 were expressed in HC11 cells, using retroviral transduction.  
A scrambled (Scr) sequence, not know to target any mammalian gene, was used as a 
negative control.  Sim2 expression was reduced approximately 50% using this technique.  
Q-PCR analysis revealed a significant decrease in the amount of Csn2 in cells with 
reduced Sim2 using the construct targeting Exon 6 (siSim2), when compared to Scr 
controls (Fig. 20A).  Similar results were obtained using the shRNA construct targeting 
Exon 10 (data not shown).  A decrease in β-Casein protein was seen, as well, in siSim2  
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cells compared to Scr cells (Fig. 20B).  These data suggest that upregulation of Sim2s 
during HC11 cell differentiation is required for maximal Csn2 expression. 
 
Analysis of the Csn2 Proximal Promoter  
 The proximal region of the Csn2 promoter has been well characterized, and many 
of the factors that regulate expression of the gene have been identified (Kabotyanski et 
al. 2006)  Figure 21A depicts a diagram of the Csn2 gene.  Within 1 hour of Prl 
treatment, an increase in association of Stat5a, GR, C/EBPβ, and RNA Polymerase II 
(RNAPII) can be detected at the Csn2 proximal promoter.  Using ChIP analysis, 
performed on chromatin harvested from undifferentiated HC11 cells or cells treated for 
4, 8, or 24 hours with Prl, we detected a transient increase in the amount of Stat5a 
associated with the Csn2 promoter in Control cells, and a greater, sustained association 
of Stat5a in the Sim2s cells (Fig. 21B).  Western blot analysis revealed no increase in the 
amount of total Stat5a in Sim2s HC11 cells compared to Control cells (Fig. 22), so the 
difference in Stat5a found at the Csn2 promoter between the two cell types is likely due 
to enhanced recruitment in the Sim2s cells.   
 The pattern of RNAPII association with the Csn2 promoter followed that of 
Stat5a for both the Control and Sim2s cells, and higher amounts of RNAPII were found 
to be recruited to the Csn2 promoter in Sim2s cells (Fig. 21B).  The C-terminal domain 
(CTD) of RNAPII is composed of heptad repeats with the amino acid sequence 
YSPTSPS.  Phosphorylation on Serines 2 and 5 are required for promoter escape and  
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elongation of the RNAPII complex.  In Sim2s cells, more active, or Serine 2-
phosphorylated, RNAPII was found to be associated with the Csn2 promoter, when 
compared to Control cells, and this association was sustained throughout the timecourse, 
similar to that of Stat5a.  Sim2 was found to be transiently associated to the Csn2 
promoter in both the Control and Sim2s cells, although the Csn2 regulatory region does 
not contain a consensus binding site for Sim2 or other PAS proteins.  Interestingly, 
association of acetylated-Histone H3 (AcH3) with the Csn2 promoter was relatively 
constant in both Control and Sim2s cells, after hormonal stimulation.  This suggests that 
overexpression of Sim2s does not alter the accessibility of chromatin surrounding the 
Csn2 regulatory region; rather, it appears to enhance the recruitment of factors to the 
promoter after PRL stimulation.  
 ChIP analysis was also used to evaluate the factors associated with the coding 
region of the Csn2 gene (Figure 23A).  Analysis of Stat5a occupancy was used as a 
negative control, as the protein has been shown to bind the proximal promoter region 
only (Fig. 23B).  Both total and active RNAPII showed a similar pattern of association to 
that found at the promoter region, in both Control and Sim2s cells.  Greater amounts of 
both forms of RNAPII were recruited in the Sim2s cells as compared to Control cells 
(Fig. 23B).  Cdk9 is part of the P-TEFb complex that participates in promoting 
elongation of RNAPII by phosphorylating Serine 2 in the CTD.  A transient association 
of Cdk9 with the Csn2 coding region was detected in Control cells, but this recruitment 
was sustained in Sim2s cells (Fig. 23B).  Surprisingly, Sim2 was found to be associated 
with the Csn2 coding region in both Control and Sim2s cells, and the pattern of  
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recruitment was similar to that of RNAPII (Fig. 23B).  Sim2 was not detected in 
association with a coding exon of the Actb gene, and AcH3 was used as a positive 
control (Fig. 23C).  The detection of Sim2 in the coding region of Csn2 suggests that  
it interacts with the general transcriptional machinery that remains associated with DNA 
throughout the gene.     
 To determine if Sim2 and RNAPII associate with one another at specific sites in 
the Csn2 gene, Re-ChIP analysis was performed on chromatin harvested from Control 
cells treated for 4 hours with HC + Prl (Fig. 24).  This experiment revealed that Sim2 
and RNAPII were both found in a complex associated with the Csn2 proximal promoter 
and coding regions after Prl stimulation of HC11 cells.   
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CHAPTER V 
CONCLUSIONS 
 
Sim2s Expression and Cellular Differentiation 
 The Singleminded gene was initially identified in Drosophila (dsim), where it 
plays a role in cell fate determination in the CNS during embryogenesis (Menne et al. 
1997; Chang et al. 2001).  Our laboratory was the first to identify a role for mammalian 
Sim2, a dsim homolog, in normal development of the mammary epithelium, and to 
uncover a requirement for SIM2s in the maintenance of epithelial cell fate in breast 
cancer cells (Laffin et al. 2008).  It was determined that the short Sim2 isoform, Sim2s, 
was found to be highly expressed in the terminally differentiated epithelial cells of the 
mouse mammary gland (Fig. 6A).  Based on the role of dsim in cell fate determination 
and of SIM2s in maintenance of mammary epithelial cell fate, Sim2s likely participates 
in promoting and maintaining an alveolar cell fate in the mammary epithelium.  
 To test our hypothesis, we created a transgenic mouse expressing Sim2s driven 
by the MMTV-LTR in the mammary epithelium (Fig. 8),  and altered levels of Sim2s in 
the mouse mammary epithelial cell line, HC11 (Figs. 19 & 20).  The HC11 cell line 
provides a valuable resource to evaluate the regulation of milk protein gene transcription 
in response to hormonal stimulation (Ball et al. 1988).  Analysis of various tissues from 
transgenic female mice revealed transgene expression in the mammary epithelium.  The 
pattern of expression, as determined by IHC analysis of HA localization (Fig. 8C), was 
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consistent with that of previously reported MMTV-driven transgenes (Robinson et al. 
2001).   
 Morphologically, mammary gland development in transgenic female mice was 
not altered when compared to WT controls (Figs. 9 & 10).  TEB and mature ductal 
structures were normal in nulliparous females, and lobulo-alveolar formation took place 
during pregnancy.  Following pup removal after 10 days of lactation, mammary glands 
from transgenic females appeared to regress more slowly than those from WT females, 
and had fewer cleaved caspase 3-positive cells, as determined by IHC analysis (Fig. 16).  
Ultimately, the glands involuted and were able to expand again during the next 
pregnancy.   
 
Enhanced Differentiation in Vitro and in Vivo  
 During virgin development, expression of Csn2 and Wap were significantly 
upregulated in mammary glands from transgenic females compared to those from WT 
animals (Fig. 11A & B).  In addition, Npt2b was detected at the luminal surface of the 
ductal epithelial cells in approximately 70% of transgenic females (Fig. 12B).  In WT 
females, Npt2b is not detectable during virgin development, but becomes localized to the 
apical surface of the ducts during lactation (Shillingford et al. 2002).  Interestingly, there 
were no differences in Aqp5 expression or localization between WT and transgenic 
mammary glands (Fig. 12A).  Aqp5 is highly expressed and located on the luminal 
surface of ductal epithelial cells during virgin development, but is lost during pregnancy 
and lactation (Shillingford et al. 2003).  The detection of both Aqp5 and Npt2b in 
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epithelial cells of transgenic nulliparous females suggests precocious, but incomplete, 
lactogenic differentiation.  Using IHC, we detected beta-Casein sporadically produced in 
epithelial cells of transgenic females (Fig. 12C).  Moderate upregulation of Csn2 in the 
mammary epithelium is not uncommon during estrus in nulliparous females (Robinson 
et al. 1995).  With each cycle, some epithelial cells acquire the ability to transcribe small 
amounts of both Csn2 and Wap, but neither is detectable during diestrus.  Females used 
for these studies were sacrificed during estrus, so the differences between the two groups 
can be attributed to the transgene expression; however, the fate of these partially 
differentiated cells after estrus is not known.  The data, revealing a reduction in 
postlactational apoptosis following forced weaning, and showing the extrusion of Sim2-
negative epithelial cells into the alveolar lumen (Fig. 17A), suggest that differentiated 
epithelial cells in transgenic nulliparous females may accumulate with each estrus cycle 
due to enhanced cell survival.  During pregnancy, the patterns of Csn2 and Wap 
expression are identical, although Csn2 is detectable prior to Wap (Robinson et al. 
1995).   Neither shows uniform expression, and both are localized to the same alveolar 
cells in late pregnancy.  During lactation, expression of milk protein genes is high, but 
none show a uniform pattern throughout the mammary gland (Robinson et al. 1995).  
Currently, the tools are not available to distinguish between cells that do and do not 
produce Csn2 and Wap in an alveolar structure.  It is possible that the Sim2s transgene 
leads to the differentiation and survival of this cell type in the mammary epithelium after 
estrus, and endogenous Sim2s maintains this cell fate during lactation. 
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 The level of expression and pattern of PR localization in the mammary 
epithelium was reported to be developmentally regulated (Seagroves et al. 2000; 
Aupperlee et al. 2005).  In immature nulliparous femals, PR expression is high, and 
localized to nearly all luminal epithelial cells.  As the female progresses through puberty 
and ductal elongation is complete, the pattern of PR expression becomes less uniform.  It 
has been proposed that PR controls cell proliferation in the mammary gland in a 
juxtacrine manner, as PR is rarely associated with a proliferating cell in mature 
mammary glands.  Hypothetically, PR activation stimulates production of mitogenic 
factors, which are secreted and promote growth of adjacent, PR-negative, cells 
(Seagroves et al. 2000).  The uniform pattern of expression displayed by PR in immature 
virgins is likely a mechanism to prevent precocious side branching and cell proliferation 
prior to the completion of branching morphogenesis.  During pregnancy, the relative 
amount of PR positive cells decreases, and no PR is detectable during lactation 
(Aupperlee et al. 2005).   
 In mammary glands of mature nulliparous transgenic females, differences were 
not detected in distribution or expression levels of PR, when compared to WT glands 
(Fig. 13A).  In early pregnancy, however, there were significantly fewer PR positive 
cells in epithelial cells of transgenic glands compared to WT glands (Fig. 13B).  This 
decrease in PR expression could reflect a globally more differentiated gland in the 
transgenic females.  During late pregnancy, relatively few cells expressed PR, and 
differences were not observed between WT and transgenic glands (Fig. 13C).  It is 
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possible that, during late pregnancy, expression of PR is too low to detect any significant 
differences between the groups.   
 In addition to evaluating expression of PR during pregnancy, we analyzed the 
expression of milk protein genes in glands from WT and transgenic females at P6 and 
P16 (Fig. 14).  Significant increases were observed in expression of Expi, Lalba, Csn2 
and Wap in early pregnancy in glands from transgenic females.  In the WT mammary 
gland, early pregnancy is associated with rapid cell proliferation and alveolar formation, 
but alveolar epithelial cells have not yet undergone secretory differentiation.  At this 
stage, endogenous Sim2s expression was relatively low (Fig. 6).  By P16, significant 
differences were not detected in expression of the four listed milk protein genes between 
WT and transgenic glands.  In late pregnancy, the alveolar epithelial cells continue to 
proliferate, but are beginning to undergo secretory differentiation, characterized by 
accumulation of CLDs and moderate expression of milk protein genes.  Our data 
indicate that precocious Sim2s expression, during early pregnancy, promotes moderate 
upregulation of milk protein gene expression, but by late pregnancy, expression is high 
enough to render undetectable any changes due to transgene expression.   
 
Sim2s and Lactation 
 At parturition, several changes take place in the mammary gland that promote 
abundant milk production for the newborn offspring;  Circulating levels of P4 decrease 
and Prl levels surge, which ensures high transcription rates of essential genes.  Milk 
protein gene expression is dramatically upregulated and select mRNAs become 
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stabilized.  Although expression of Expi, Lalba, Csn2 and Wap is greatly enhanced, they 
continue to show a non-uniform pattern of expression throughout an alveolar unit 
(Robinson, 1995).  In addition, we have shown that Expi and Lalba were most highly 
expressed immediately following parturition, and did not increase further during the first 
week of lactation (Fig. 7D & E).  On the contrary, expression of Csn2 and Wap 
continued to increase during that week, peaking at L7 (Fig. 7B & C).  Interestingly, 
Sim2s expression followed that exact pattern (Fig. 7A).  These results, taken with the 
non-uniform expression pattern, suggest that all milk protein genes are not regulated by 
the same mechanisms, and that Sim2s may be involved in fine-tuning the expression of 
certain genes during lactation.   
 Loss-of-function studies, performed on some of these genes, reflect different 
requirements of their expression for pup survival.  It has been reported that loss of Csn2 
(Kumar et al. 1994) or Wap (Triplett et al. 2005) does not result in pup mortality.  Csn2-/- 
mammary glands produce milk with a slightly altered protein composition, and pups 
nursed by Csn2-deficient mothers are runted, but they survive.  Loss of Wap does not 
result in pup growth defects during the first 8 days of lactation.  It is only during the last 
half of lactation that pup growth becomes slower and the offspring are significantly 
smaller.  This indicates that maximal expression of Wap and Csn2 immediately after 
parturition is not required for the survival of the offspring.  It is likely that the mammary 
tissue has evolved mechanisms to prevent the unnecessary use of valuable resources 
during lactation, and these mechanisms involve precise control of gene expression.  
Conversely, loss of Lalba in the mammary gland leads to pup mortality within 8 hours of 
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their birth (Stacey et al. 1995).  Alpha-lactalbumin is a subunit of the lactose synthetase 
enzyme.  Lactose, a major milk carbohydrate, helps move water into the milk and is 
responsible for its fluidity.  Milk produced by Lalba-/- mothers is highly viscous and 
cannot be expelled from the ducts.  In this case, maximal expression of the Lalba gene at 
parturition is clearly necessary for the survival of the offspring.  Currently, there are no 
reported loss-of-function studies on Expi.  Based on the expression of Sim2s during 
lactation and the effect of the Sim2s transgene on Csn2 and Wap levels during virgin 
development, it is possible that, during lactation, Sim2s functions to participate in the 
precise control of the expression of a subset of milk protein genes in specific cells. 
 Analysis of milk protein gene expression during the first week of lactation in WT 
and transgenic females revealed interesting results (Fig. 15).  In WT glands, the 
expression of Csn2 and Wap increased from L2 to L4 (Fig. 15C & D).  Differences were 
not detected in Wap expression between glands from transgenic and WT females; 
however, we did observe a statistically significant increase in Csn2 expression in glands 
from transgenic females at L4, when compared to WT glands (Fig. 15C).  Significant 
differences were not detected in either Expi or Lalba expression at L2 or L4 in WT or 
transgenic glands (Fig. 15A & B).  Overall, precocious expression of Sim2s in the 
mammary epithelium resulted in accelerated differentiation of the mammary epithelium, 
characterized by developmental stage-specific upregulation of certain milk protein 
genes.  In addition, other changes associated with lactogenic differentiation took place in 
the mammary glands of transgenic females, including upregulation of Npt2b and loss of 
PR expression.  During the first week of lactation, however, only Csn2 was significantly 
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upregulated.  In the next section, the possible mechanism contributing to enhanced Csn2 
expression will be discussed.   
 
Regulation of Csn2 Transcription  
 As described previously, the HC11 cell model provides an excellent system to 
study regulation of Csn2 transcription.  Within 15 minutes of hormonal stimulation, 
Stat5a, GR, and RNAPII are recruited to the Csn2 promoter, and mRNA can be detected 
2 hours later (Kabotyanski et al. 2006).  Using HC11 cells, we have shown that Sim2s 
expression increases with hormone treatment, in a similar pattern seen during the first 
week of lactation in vivo (Fig. 18A).  Overexpression of Sim2s was not sufficient to 
induce Csn2 in the absence of Prl; however, it resulted in significantly enhanced steady-
state levels of Csn2 mRNA in the presence of Prl, and this difference was detected as 
early as 4 hours after hormone treatment (Fig. 19A).  Reduction of Sim2s levels, using 
shRNA, resulted in attenuated Csn2 expression and beta-Casein production (Fig. 20A & 
B).  Together, these data suggest that, in HC11 cells, Sim2s is necessary for maximal 
Prl-induced Csn2 expression.   
 ChIP analysis of the Csn2 proximal promoter region revealed transient increases 
in the association of Stat5a and RNAPII in control cells (Fig. 21B).  Interestingly, Sim2 
was found to be associated with this region as well, although there are no consensus 
binding sites for the protein in the Csn2 promoter (not shown).  The relative amounts of 
Stat5a and RNAPII recruited to the Csn2 promoter were markedly higher in the Sim2s 
cells, and they remained associated for 24 hours.  As reported previously, the Csn2 
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promoter region was found to be associated with acetylated Histone H3 (AcH3), 
consistent with genes undergoing active transcription.  The pattern and relative amounts 
of AcH3 at the Csn2 promoter did not differ between Control and Sim2s cells.  These 
data indicate that Sim2s overexpression may enhance recruitment of Stat5a and RNAPII 
to a given Csn2 promoter, rather than stimulating accessibility of more promoters in a 
population of cells.  In addition to enhanced stability of the Csn2 mRNA, an increase in 
the transcription rate of the Csn2 gene has been reported in HC11 cells after Prl 
treatment (Ball et al. 1988).  Although not evaluated in this model, it is possible that 
Sim2s participates in altering the rate of transcription of Csn2 in response to Prl in HC11 
cells, and possibly in vivo.   
 ChIP analysis was also used to evaluate the factors associated with the Csn2 
coding region (Fig. 23B).  Similar to what was detected at the proximal promoter, in 
Control cells RNAPII and Sim2s were both found to be transiently associated with Csn2 
Exon VII, and the association was greater in Sim2s cells.  Stat5a was not detected in this 
region in either cell type.  Cdk9, a subunit of P-TEFb, known to promote transcription 
elongation by phosphorylating Serine 2 of the RNAPII CTD, was found to be recruited 
to the Csn2 coding region in a similar pattern to RNAPII in both cell types.  In addition, 
RNAPII and Sim2 were found to be in a complex at both the proximal promoter and 
ExonVII, by Re-ChIP analysis (Fig. 24).  These results indicate that Sim2s associates 
with RNAPII beyond the proximal promoter region of the Csn2 gene.  It is possible that 
Sim2s serves as a cell type-, or differentiation stage-specific subunit of the RNAPII 
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holoenzyme complex to promote transcription under hormonal stimulation.  The precise 
mechanism by which Sim2 accomplishes this has not been investigated. 
 
The Function of Sim2s in the Mammary Epithelium 
 In these studies, we have determined that the expression of Sim2s in the mouse 
mammary gland is developmentally regulated and peaks during the first week of 
lactation.  In addition, precocious expression of Sim2s in vivo promotes an alveolar 
epithelial cell phenotype, characterized by upregulation of milk protein gene expression 
in glands from nulliparous and pregnant transgenic females, production and proper 
localization of Npt2b, and reduction of PR during early pregnancy.  Milk protein gene 
expression, in vivo, is not uniform during pregnancy or even during lactation (Robinson 
et al. 1995).  The increased expression of some milk protein genes in mammary glands 
of transgenic nulliparous females suggests that a subpopulation of differentiated alveolar 
cells is over-represented in this model, perhaps due to prolonged cell survival.  Several 
studies have been performed to evaluate the signature of the mammary stem cell, both 
during normal development and oncogenic transformation (Vaillant et al. 2007).  The 
identified markers allow certain cell types to be isolated, and many investigators have 
associated the expression of other genes, many localized to the nucleus, with these 
various surface markers.  Unfortunately, the markers that would allow the identification 
of specific alveolar epithelial cells that produce Wap and Csn2 during estrus are not 
available.   
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 The question remains, what is the function of a protein that is identified as cell 
type specific, i.e. progenitor, luminal, alveolar, or myoepithelial?  One striking 
difference between progenitor cells and their differentiated daughters, in many tissues, is 
the array of genes that are expressed.  In many systems, specific genes are upregulated 
during cell commitment processes that ultimately define the function of the tissue.  It is 
likely, then, that some proteins can alter global transcription within a cell when they are 
produced.  The observation that Sim2s promotes the expression of genes associated with 
differentiation is consistent with the previously published role for Sim2 as a putative 
mammary tumor suppressor (Kwak et al. 2007).  In the mouse PyMT mammary tumor 
model, for example, the progression from adenoma to adenocarcinoma involves the loss 
of cellular differentiation (Kouros-Mehr et al. 2008).  Our data, from HC11 cells, 
showed recruitment of RNAPII and Stat5a to the Csn2 promoter in the presence of 
Sim2s, and revealing an association of Sim2s and RNAPII at the proximal promoter and 
coding exon of Csn2, suggest that Sim2s participates in recruiting transcriptional 
machinery to the regulatory region of differentiation-specific genes.  It is possible that 
the inverse relationship between Sim2s expression and cancer cell aggressiveness 
involves the effect of Sim2s on tumor cell differentiation.   
 The conformation and subunit composition of the general transcription factors 
can vary depending on the tissue, the cell type within a tissue, or the developmental 
stage of the tissue.  In Drosophila spermatocyte development, it has been proposed that 
transcriptional complexes can vary in the composition of TBP-associated factors (TAFs) 
that together with TBP form TFIID, to regulate the expression of testis-specific genes 
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(Hiller et al. 2004).  TFIID associates with promoters of genes to recruit RNAPII and 
promote transcription initiation.  In mice, it has been shown that the cellular localization 
of a TAF is another level of transcriptional regulation during differentiation (Pointud et 
al. 2003).  TAF7L was identified as a germ cell-specific paralog of TAF7.  In 
spermatogonia, TAF7L is localized to the cytoplasm, but becomes nuclear and replaces 
TAF7 in the TFIID complex during spermatogenesis.  A study performed in mouse 
ovaries determined that loss of TAF105 affected expression of a subset of genes 
associated with follicle development (Freiman et al. 2001).  The authors proposed that 
cell type specific subunits of TFIID in mammalian cells lead to specific regulation of 
gene expression programs during differentiation.  Cell type specific replacements for 
TBP have been identified in spermatocytes and developing myotubules, as well (Zhang 
et al. 2001; Deato and Tjian 2007).  
 Based on these studies and our data, we propose a model in which Sim2s is 
expressed in a developmentally-regulated, and possibly cell type specific manner, to 
interact with RNAPII and its associated factors and promote expression of genes 
associated with lactogenic differentiation in the mammary gland (Figs. 25 & 26).  In 
addition, we hypothesized that Sim2s plays a role in alveolar cell survival during 
lactation, which is likely not exclusive from its role in transcription regulation.  Future 
studies will most certainly involve loss of Sim2s function and analysis of altered 
transcription programs, and also biochemical assays to evaluate the potential interactions 
between Sim2s and components of the general transcription machinery.    
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